Otofacial Neurodevelopmental Syndrome

Mendelian MONDO:0975705 Pathograph 22 Show in embeddings browser Neurodevelopmental Disorder Intellectual Disability

Otofacial neurodevelopmental syndrome is an autosomal recessive syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10, which encodes a SCAN-domain C2H2 zinc-finger transcription factor of the embryonic stem cell pluripotency network (a direct partner and regulator of OCT4/POU5F1 and SOX2). The disorder was delineated in 2024 in seven affected individuals from five unrelated families. The consistent clinical triad is global developmental delay with mild-to-severe cognitive impairment, facial asymmetry (often with unilaterally reduced facial movements or hypotonic facies), and malformations of the outer ear. Cranial MRI demonstrates semicircular canal dysplasia or aplasia as the anatomical correlate of sensorineural hearing loss. Variable additional features include delayed motor development, absent or minimal expressive language, behavioural abnormalities with autistic features, downslanted palpebral fissures, prominent epicanthic folds, microgenitalia, cleft palate, and cardiac malformation. Because facial asymmetry, ear malformation and hearing loss co-occur, the phenotype is clinically confusable with CHARGE syndrome and with the oculo-auriculo-vertebral (Goldenhar) spectrum.

Ask OpenScientist

Ask a research question about Otofacial Neurodevelopmental Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
20
Phenotypes
2
Gaps
22
Pathograph
1
Genes
4
Medical Actions
2
Differentials
2
Models
2
References
2
Deep Research
🏷

Classifications

Harrison's Part
GENETICS ENVIRONMENT DISEASE NEUROLOGIC
👪

Inheritance

1
Autosomal recessive HP:0000007
All reported affected individuals carry bi-allelic (homozygous or compound heterozygous) ZSCAN10 protein-truncating variants, with full co-segregation in tested family members and no homozygous ZSCAN10 protein-truncating variants in gnomAD. Several families originate from consanguineous or geographically neighbouring Iranian and Pakistani populations sharing a common founder allele.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
Bi-allelic variants in multiple unrelated families establish autosomal recessive inheritance.
PMID:38386308 SUPPORT Human Clinical
"Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10."
The paper's conclusion states the bi-allelic loss-of-function basis of the disorder.
?

Discussions and Knowledge Gaps

2
How does loss of a transcription factor whose best-characterized role is maintenance of embryonic stem cell pluripotency produce a spatially specific oto-facial malformation phenotype rather than a global embryonic defect?
KNOWLEDGE GAP OPEN zscan10_pluripotency_to_craniofacial_gap
Attached to
pathophysiology#Dysregulation of the Pluripotency Transcriptional Network pathophysiology#Disturbed Craniofacial and Otic Morphogenesis
ZSCAN10 expression is highest in embryonic stem cells and falls sharply with differentiation, yet the human phenotype is dominated by asymmetric craniofacial and otic malformations. The intervening cell populations (plausibly cranial neural crest and otic placode derivatives) and the developmental window in which ZSCAN10 loss becomes consequential have not been identified, which is why the causal edge from network dysregulation to craniofacial morphogenesis is curated with unknown intermediates.
Proposed experiments
Lineage-resolved single-cell transcriptomics of Zscan10-null embryos
zscan10_lineage_scrnaseq
Single-cell RNA-seq of Zscan10-/- and wild-type mouse embryos sampled across the otic placode and cranial neural crest stages, to identify which lineage first diverges transcriptionally.
Decision criterion
A lineage showing significant divergence before overt morphological abnormality identifies the primary affected progenitor population.
Conditional tissue-restricted Zscan10 deletion
zscan10_conditional_deletion
Conditional Zscan10 deletion restricted to cranial neural crest or to otic epithelium, to test whether the malformation is cell-autonomous to either lineage.
Decision criterion
Reproduction of the oto-facial malformation by a tissue-restricted deletion demonstrates a cell-autonomous requirement in that lineage.
Stage-specific ZSCAN10 enhancer mapping
zscan10_stage_specific_chipseq
ZSCAN10 ChIP-seq in human neural crest and otic organoid models to identify stage-specific enhancer targets beyond the pluripotency network.
Decision criterion
Identification of craniofacial or otic developmental enhancers bound by ZSCAN10 outside the pluripotent state would supply the missing intermediate.
Show evidence (2 references)
PMID:38386308 SUPPORT In Vitro
"RNA-sequencing analyses in Zscan10-/- mESCs indicated dysregulation of genes related to stem cell pluripotency."
The only mechanistic readout available is in the pluripotent state, which is precisely why the step from there to the craniofacial phenotype is a gap.
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
The spatially restricted oto-facial human phenotype is what the pluripotency-network readout does not explain.
Do the extra-craniofacial phenotypes of Zscan10 mutant mice (organ and eye malformations, reduced weight, spleen, heart and long bone hypoplasia) have human counterparts, or is the mouse model over-reporting relative to human ZSCAN10 deficiency?
HUMAN MODEL MISMATCH OPEN zscan10_mouse_human_phenotype_mismatch
Attached to
pathophysiology#Disturbed Craniofacial and Otic Morphogenesis
The earlier Zscan10 mutant mouse line shows reduced weight, mild spleen, heart and long bone hypoplasia, and a Sox2-hypomorph-like eye malformation. The original human study explicitly notes that these organ and eye malformations were not observed in its clinical cohort, while the facial and ear findings were strikingly concordant. With only seven reported individuals, absence of the extra-craniofacial features in humans may reflect ascertainment and cohort size rather than true species divergence. In addition, high embryonic lethality of the homozygous knockout in the newer line precluded adult mouse phenotyping, limiting comparison to the postnatal human phenotype.
Proposed experiments
Systematic multisystem assessment of an expanded human cohort
zscan10_expanded_cohort_multisystem
Systematic ophthalmological, splenic, cardiac and skeletal assessment in an expanded human ZSCAN10 cohort assembled through GeneMatcher.
Decision criterion
Detection of eye or visceral hypoplasia at above-background frequency in a larger human cohort would resolve the apparent mismatch as ascertainment.
Postnatal phenotyping of surviving Zscan10 mutant mice
zscan10_adult_mouse_phenotyping
Deep phenotyping of surviving adult Zscan10 mutant mice on a permissive genetic background, including facial morphometry and inner ear imaging not performed in the original German Mouse Clinic pipeline.
Decision criterion
Concordance of adult mouse and human postnatal phenotypes would establish the model's translational validity beyond the embryonic stage.
Show evidence (1 reference)
PMID:25111779 SUPPORT Model Organism
"Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs."
Documents the mouse phenotypes whose human counterparts are uncertain.
⚙

Pathophysiology

6
ZSCAN10 Bi-allelic Loss of Function
Bi-allelic protein-truncating variants in ZSCAN10 remove the function of a SCAN-domain C2H2 zinc-finger transcription factor. All four reported disease alleles are protein-truncating variants located in the large terminal exon 6, which encodes 66% of the protein including all 14 C2H2 zinc-finger motifs. Truncating alleles here are predicted to escape nonsense-mediated decay only partially; any translated product lacks a variable fraction of the zinc-finger array.
ZSCAN10 hgnc:12997 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ZSCAN10 (hgnc:12997). hgnc:12997 is a gene from the HUGO Gene Nomenclature Committee.
DNA-binding transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased DNA-binding transcription factor activity (GO:0003700). GO:0003700 is a molecular function from the Gene Ontology. ↓ DECREASED
Downstream
Mislocalization and Loss of Enhancer Binding
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
Human genetic evidence establishes bi-allelic ZSCAN10 loss of function as the molecular cause.
PMID:16971461 SUPPORT In Vitro
"the putative SCAN-Zinc finger transcription factor Zfp206 is expressed specifically in ES cells"
Establishes ZSCAN10/Zfp206 as a SCAN-zinc-finger transcription factor of embryonic stem cells.
Mislocalization and Loss of Enhancer Binding
The recurrent human p.(Gln486*) truncating variant, modelled in mouse embryonic stem cells, alters ZSCAN10 expression level and shifts the protein from a predominantly nuclear to a predominantly cytoplasmic distribution. The truncated protein loses binding at ZSCAN10 DNA enhancer and promoter targets, including the POU5F1 (Oct4) promoter, providing the molecular loss-of-function mechanism.
ZSCAN10 hgnc:12997 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ZSCAN10 (hgnc:12997). hgnc:12997 is a gene from the HUGO Gene Nomenclature Committee.
protein import into nucleus GO:0006606 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased protein import into nucleus (GO:0006606). GO:0006606 is a biological process from the Gene Ontology. ↓ DECREASED
DNA-binding transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased DNA-binding transcription factor activity (GO:0003700). GO:0003700 is a molecular function from the Gene Ontology. ↓ DECREASED
nucleus GO:0005634 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves decreased nucleus (GO:0005634). GO:0005634 is a cellular component from the Gene Ontology.
Downstream
Dysregulation of the Pluripotency Transcriptional Network
Show evidence (2 references)
PMID:38386308 SUPPORT In Vitro
"we established in mESCs the loss-of-function mechanism for a representative human ZSCAN10 protein truncating variant by showing alteration of its expression levels and subcellular localization, interfering with its binding to DNA enhancer targets."
Directly documents altered subcellular localization and loss of enhancer binding for the truncating variant.
PMID:19740739 SUPPORT In Vitro
"We show that Zfp206 binds to the Oct4 promoter and directly regulates Oct4 expression."
Independently establishes the POU5F1/Oct4 promoter as a direct ZSCAN10 binding target whose occupancy is lost in the mutant.
Dysregulation of the Pluripotency Transcriptional Network
ZSCAN10 is an integrated component of the core OCT4/SOX2/NANOG pluripotency network and binds more than 3000 target genes in embryonic stem cells. Its loss dysregulates genes governing stem cell pluripotency and differentiation (including Pou5f1, Sall4, Mtf2, Hoxb13 and Meis2 in knockout mouse embryonic stem cells), shifting the balance between progenitor maintenance and fate commitment during early embryogenesis. This node is the least certain step in the chain: an independent inducible-knockout study found Zscan10-null mouse embryonic stem cells to be fully self-renewing and pluripotent, so ZSCAN10 is probably not strictly required for baseline pluripotency maintenance. The disease-relevant defect may instead lie in progenitor fate choice during later embryogenesis rather than in the pluripotent state itself.
embryonic stem cell CL:0002322 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves embryonic stem cell (CL:0002322). CL:0002322 is a cell type from the Cell Ontology.
stem cell population maintenance GO:0019827 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal stem cell population maintenance (GO:0019827). GO:0019827 is a biological process from the Gene Ontology. ⚠ ABNORMAL regulation of transcription by RNA polymerase II GO:0006357 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of transcription by RNA polymerase II (GO:0006357). GO:0006357 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Disturbed Craniofacial and Otic Morphogenesis
Impaired Neurodevelopment
Show evidence (7 references)
PMID:38386308 SUPPORT In Vitro
"RNA-sequencing analyses in Zscan10-/- mESCs indicated dysregulation of genes related to stem cell pluripotency."
Knockout embryonic stem cells show dysregulation of the pluripotency gene programme.
PMID:19740739 SUPPORT In Vitro
"Genome-wide mapping of Zfp206-binding sites in ESC identifies more than 3000 target genes, many of which encode transcription factors that are also targeted for regulation by Oct4 and Sox2."
Establishes the breadth of the ZSCAN10 target network and its overlap with OCT4/SOX2.
PMID:17628018 SUPPORT In Vitro
"We found that Zfp206 was able to enhance expression from its own promoter and also activate transcription of the Oct4 and Nanog promoters."
ZSCAN10 transactivates the OCT4 and NANOG promoters, so its loss removes positive drive on the pluripotency network.
+ 4 more references
Disturbed Craniofacial and Otic Morphogenesis
Loss of ZSCAN10 transcriptional output perturbs the developmental programmes that shape the face and both the external ear and the membranous labyrinth of the inner ear. In affected individuals this manifests as facial asymmetry with subtle osseous asymmetry of the skull and midface, outer ear dysplasia, and semicircular canal dysplasia or aplasia. Zscan10-deficient mouse embryos recapitulate the asymmetric facial shape change together with reduced ear opening and misalignment of a semicircular canal with cochlear shortening, indicating a conserved developmental mechanism.
semicircular canal morphogenesis GO:0048752 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal semicircular canal morphogenesis (GO:0048752). GO:0048752 is a biological process from the Gene Ontology. ⚠ ABNORMAL outer ear morphogenesis GO:0042473 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal outer ear morphogenesis (GO:0042473). GO:0042473 is a biological process from the Gene Ontology. ⚠ ABNORMAL
face UBERON:0001456 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in face (UBERON:0001456). UBERON:0001456 is an anatomical location from the Uberon multi-species anatomy ontology. semicircular canal UBERON:0001840 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in semicircular canal (UBERON:0001840). UBERON:0001840 is an anatomical location from the Uberon multi-species anatomy ontology. external ear UBERON:0001691 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in external ear (UBERON:0001691). UBERON:0001691 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Facial Asymmetry
Outer Ear Malformation
Inner Ear Labyrinthine Malformation
Cleft Palate
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Establishes facial asymmetry and outer ear malformation as consistent human features of the disorder.
PMID:38386308 SUPPORT Model Organism
"Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
The Zscan10 mouse model reproduces the facial and ear malformation phenotype, supporting a conserved developmental mechanism.
Inner Ear Labyrinthine Malformation
Dysplasia or aplasia of the semicircular canals with vestibular dysmorphology is demonstrable on cranial MRI and is the structural inner ear correlate of the sensorineural hearing loss seen in this disorder. Notably, despite the vestibular malformation, vertigo and imbalance were not reported in the original cohort.
semicircular canal development GO:0060872 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal semicircular canal development (GO:0060872). GO:0060872 is a biological process from the Gene Ontology. ⚠ ABNORMAL
semicircular canal UBERON:0001840 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in semicircular canal (UBERON:0001840). UBERON:0001840 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Semicircular Canal Dysplasia
Sensorineural Hearing Loss
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Directly states semicircular canal dysplasia as the anatomical correlate of the hearing loss.
Impaired Neurodevelopment
ZSCAN10 expression falls with developmental age but remains detectable postnatally in brain, testis and pituitary gland. Loss of function produces global developmental delay with mild-to-severe cognitive impairment, markedly delayed motor milestones, delayed or absent expressive language, and behavioural abnormalities. Cranial MRI in the reported individuals showed no structural cerebral anomaly beyond the inner ear findings, so the cellular substrate of the cognitive phenotype remains undefined.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
nervous system development GO:0007399 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal nervous system development (GO:0007399). GO:0007399 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Global Developmental Delay
Intellectual Disability
Motor Delay
Delayed Speech and Language Development
Autistic Behavior
Aggressive Behavior
Hyperphagia
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Global developmental delay is one of the three consistent clinical features of the disorder.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Otofacial Neurodevelopmental Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

20
Cardiovascular 1
Cardiac Malformation Abnormal heart morphology HP:0001627 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cardiac malformation, annotated with Abnormal heart morphology (HP:0001627). HP:0001627 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Cardiac malformation is recorded for one of the seven individuals in the study's clinical table; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Ear 1
Sensorineural Hearing Loss FREQUENT Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Sensorineural hearing loss is documented as the functional consequence of the inner ear malformation. Denominator decision (recorded deliberately, not incidental): the paper reports hearing loss in 4 of 5 individuals in whom hearing was formally assessed (80%, which would be VERY_FREQUENT) but 4 of the full 7-individual cohort (57%, FREQUENT). FREQUENT is chosen because the two unassessed individuals are of unknown status rather than known-unaffected, so the assessed-only denominator would overstate the band by conditioning on ascertainment. The abstract snippet quantifies neither denominator; both counts come from Table 1 and are therefore not directly quotable (see the entry-level notes).
Eye 1
Visual Impairment HP:0000505 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Vision impairment, annotated with Visual impairment (HP:0000505). HP:0000505 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Vision impairment is recorded for three of the seven individuals in the study's clinical table; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Genitourinary 2
Micropenis HP:0000054 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microgenitalia, annotated with Micropenis (HP:0000054). HP:0000054 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Microgenitalia is recorded for two of the seven individuals in the study's clinical table and discussed as a consequence of residual testicular ZSCAN10 expression; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Cryptorchidism HP:0000028 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Maldescended testis, annotated with Cryptorchidism (HP:0000028). HP:0000028 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Maldescended testis is recorded for one of the seven individuals in the study's clinical table and discussed as a consequence of residual testicular ZSCAN10 expression; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Head and Neck 4
Facial Asymmetry FREQUENT HP:0000324 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Facial asymmetry (HP:0000324), qualified as course stable; congenital onset. HP:0000324 is a phenotype from the Human Phenotype Ontology.
Course: STABLE Onset: CONGENITAL
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
Machine-learning portrait analysis confirms facial asymmetry as a consistent clinical feature.
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Supports the disease-phenotype association. The band is set to FREQUENT (30-79%) rather than VERY_FREQUENT on the strength of the paper's per-individual clinical table, which records facial asymmetry in 5 of 7 affected individuals (71%). The abstract's "consistent clinical features" wording is qualitative and does not by itself pin the band; per docs/frequency-evidence-guidelines.md a quantified count takes precedence over verbal hedging. Table 1 is outside the abstract and therefore not directly quotable here (see the entry-level notes on abstract-only caching).
Cleft Palate HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Cleft palate is recorded for one of the seven individuals in the study's clinical table; the abstract establishes only the seven-individual dysmorphic cohort, so this is graded INDIRECT.
Downslanted Palpebral Fissures HP:0000494 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Down slanting palpebral fissures, annotated with Downslanted palpebral fissures (HP:0000494). HP:0000494 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Downslanting palpebral fissures are itemised among the common dysmorphic features in the study's results text; the abstract only establishes the dysmorphic cohort, so this is graded INDIRECT.
Epicanthus HP:0000286 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent epicanthic folds, annotated with Epicanthus (HP:0000286). HP:0000286 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Prominent epicanthic folds are itemised among the common dysmorphic features in the study's results text; the abstract only establishes the dysmorphic cohort, so this is graded INDIRECT.
Nervous System 7
Global Developmental Delay VERY_FREQUENT HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Deep phenotyping identifies global developmental delay as a consistent feature, supporting a very frequent occurrence.
Intellectual Disability VERY_FREQUENT HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cognitive impairment, annotated with Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
The abstract reports global developmental delay as a consistent feature; the mild-to-severe grading of cognitive impairment is given in the paper's Table 1 and discussion rather than the abstract, so this is marked INDIRECT.
Motor Delay HP:0001270 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delay of motor development, annotated with Motor delay (HP:0001270). HP:0001270 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Motor delay is a component of the reported global developmental delay; the abstract does not itemise motor milestones separately, so this is marked INDIRECT.
Delayed Speech and Language Development HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed or absent expressive language, annotated with Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Speech delay is a component of the global developmental delay reported by deep phenotyping; the abstract does not itemise it, so this is marked INDIRECT.
Autistic Behavior HP:0000729 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Behavioural abnormalities with autistic features, annotated with Autistic behavior (HP:0000729). HP:0000729 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
The abstract establishes the seven-individual neurodevelopmental cohort; the behavioural abnormalities with autistic features are documented in the paper's Table 1, Results and discussion rather than the abstract, so this is marked INDIRECT.
Aggressive Behavior HP:0000718 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aggression, annotated with Aggressive behavior (HP:0000718). HP:0000718 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Aggression is recorded for two of the seven individuals in the study's clinical table; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Hyperphagia Polyphagia HP:0002591 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Excessive hyperphagia, annotated with Polyphagia (HP:0002591). HP:0002591 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Excessive hyperphagia is recorded for one of the seven individuals in the study's Results text; the abstract establishes only the seven-individual cohort, so this is graded INDIRECT.
Other 4
Unilaterally Reduced Facial Movement Unilateral facial palsy HP:0012799 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Unilaterally reduced facial movement, annotated with Unilateral facial palsy (HP:0012799). HP:0012799 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
The abstract establishes facial asymmetry as a consistent feature; the unilaterally reduced facial movement that accompanies it is described in the paper's phenotype narrative and clinical table rather than the abstract, so this is marked INDIRECT. No frequency band is asserted because no citable count is available in the cached abstract.
Motor Stereotypy HP:0000733 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Stereotypic movements, annotated with Motor stereotypy (HP:0000733). HP:0000733 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
The abstract establishes only the seven-individual neurodevelopmental cohort; the stereotypic movements are recorded in the paper's clinical table and Results text rather than the abstract, so this is marked INDIRECT. No frequency band is asserted for the same reason.
Outer Ear Malformation VERY_FREQUENT Abnormality of the outer ear HP:0000356 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Outer ear malformation, annotated with Abnormality of the outer ear (HP:0000356), qualified as course stable; congenital onset. HP:0000356 is a phenotype from the Human Phenotype Ontology.
Course: STABLE Onset: CONGENITAL
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Outer ear malformation is one of the three consistent clinical features defining the syndrome.
Semicircular Canal Dysplasia Abnormal semicircular canal morphology HP:0011380 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Semicircular canal dysplasia, annotated with Abnormal semicircular canal morphology (HP:0011380), qualified as course stable; congenital onset. HP:0011380 is a phenotype from the Human Phenotype Ontology.
Course: STABLE Onset: CONGENITAL
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Directly documents semicircular canal dysplasia on cranial MRI in affected individuals.
🧬

Genetic Associations

1
ZSCAN10 bi-allelic loss-of-function variants (Causative)
Gene: ZSCAN10 hgnc:12997 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is ZSCAN10 (hgnc:12997). hgnc:12997 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
Establishes bi-allelic ZSCAN10 loss-of-function variation as causative in the reported cohort.
💊

Medical Actions

4
Cochlear Implantation
Category: Therapeutic Action: implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is implantation, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
For profound bilateral sensorineural hearing loss, cochlear implantation bypasses the failed cochlear transduction by stimulating the auditory nerve directly. Candidacy assessment in this disorder is not routine: the labyrinthine malformation that causes the hearing loss also alters implant anatomy, so dedicated temporal bone imaging must precede implantation to define the cochlear lumen, the course of the facial nerve, and the risk of a perilymph gusher associated with vestibular and semicircular canal dysplasia. Malformed cochleae remain implantable, but electrode choice, surgical approach and counselling about expected outcome all depend on the imaging.
Mechanism Target:
BYPASSES Inner Ear Labyrinthine Malformation — A cochlear implant does not correct the developmental labyrinthine malformation; it works around the resulting transduction failure by delivering electrical stimulation directly to the auditory nerve. The same malformation constrains how the device can be placed, which is why implant candidacy in this disorder is anatomy-dependent.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Establishes the sensorineural hearing loss that motivates audiological management; the paper reports no treatment data, so this is graded INDIRECT.
PMID:41191133 SUPPORT INDIRECT Other
"hearing loss can serve as an early marker of systemic neurogenetic disease that may offer a window of opportunity for timely intervention"
A 2025 review of neurogenetic disorders with hearing loss supports early audiological identification and intervention as the management rationale. It is a narrative review covering 38 genes and does not name ZSCAN10 in its abstract, so this supports the general framing only and is graded INDIRECT.
Hearing Amplification
Category: Therapeutic Action: hearing amplificationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hearing amplification, annotated with Therapeutic Procedure (NCIT:C49236), qualified as medical device hearing aid. NCIT:C49236 is a clinical intervention from the NCI Thesaurus. Ontology label: Therapeutic Procedure NCIT:C49236
For the unilateral and non-profound bilateral hearing loss that made up most of the reported cohort, conventional amplification is the first-line rehabilitation. Because the loss is congenital and coexists with global developmental delay and expressive language delay, early fitting matters disproportionately here - untreated hearing loss compounds the language delay that is already part of the syndrome.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology. Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41191133 SUPPORT INDIRECT Other
"hearing loss can serve as an early marker of systemic neurogenetic disease that may offer a window of opportunity for timely intervention"
Supports early identification and intervention for hearing loss in neurogenetic disease as the rationale for prompt amplification. The review does not name ZSCAN10 in its abstract, so this supports the general framing only and is marked as INDIRECT.
Developmental and Educational Support
Category: Therapeutic Action: RehabilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. NCIT:C15315
Early intervention with physical, occupational and speech-language therapy is indicated for the global developmental delay, motor delay and delayed or absent expressive language. Augmentative and alternative communication should be considered for individuals without expressive language, particularly where hearing loss compounds the language delay.
Target Phenotypes: Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology. Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
Establishes the developmental delay that motivates early intervention; the paper reports no treatment data, so this is graded INDIRECT.
Genetic Counseling
Category: Counseling / Informational Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal recessive inheritance implies a 25% recurrence risk for siblings. Several reported families were consanguineous or shared a founder allele present in South Asian populations, making carrier testing and counselling relevant for at-risk relatives.
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10."
The established bi-allelic (autosomal recessive) mechanism is what grounds recurrence-risk counselling.
🔬

Diagnosis

4
Molecular confirmation by exome or genome sequencing
The diagnosis is established by identifying bi-allelic (homozygous or compound heterozygous) loss-of-function variants in ZSCAN10. Trio exome or genome sequencing is the practical first-line test, since the phenotype was delineated by next-generation sequencing rather than by a pre-existing clinical gestalt. Phase must be confirmed - the two variants have to be demonstrated in trans, by parental testing where parents are available. Consanguinity or South Asian ancestry raises the prior probability of a homozygous founder allele.
genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Results: Two pathogenic or likely pathogenic ZSCAN10 loss-of-function alleles in trans establish the molecular diagnosis.
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
Directly establishes bi-allelic ZSCAN10 loss of function as the diagnostic molecular finding.
PMID:38386308 SUPPORT Human Clinical
"Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
Confirms next-generation sequencing as the diagnostic modality that identified the cohort.
Audiological assessment
Because sensorineural hearing loss is a core feature and the ear malformations are present from birth, formal audiological testing is indicated at diagnosis and on follow-up. Age-appropriate testing includes otoacoustic emissions and auditory brainstem response in infants and pure-tone audiometry in older children. Hearing loss ranged from unilateral impairment to profound bilateral loss in the reported cohort, so a normal newborn screen on one side does not exclude the diagnosis.
audiological assessment NCIT:C18020 NCI Thesaurus (NCIT)
Markers: Otoacoustic emissions, auditory brainstem response, pure-tone audiometry
Results: Uni- or bilateral sensorineural hearing loss, up to profound bilateral loss.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Establishes the sensorineural hearing loss that makes audiological assessment necessary. The specific test battery is standard audiological practice rather than a protocol stated in this paper, so this is graded INDIRECT.
Temporal bone and cerebral MRI
High-resolution imaging of the inner ear is the single most discriminating investigation. Cerebral MRI with dedicated temporal bone sequences (or high-resolution CT) demonstrates dysplasia or aplasia of the semicircular canals and vestibular dysplasia. In the reported cohort no other cerebral anomaly was found, so an otherwise normal brain MRI with isolated labyrinthine malformation is the expected pattern and should raise ZSCAN10 deficiency in a child with developmental delay and ear anomalies.
magnetic resonance imaging NCIT:C16809 NCI Thesaurus (NCIT)
Results: Dysplasia or aplasia of the semicircular canals with vestibular dysplasia, typically without other cerebral malformation.
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Directly documents the diagnostic imaging finding and the modality that demonstrates it.
Computational facial gestalt analysis
Automated 2D portrait analysis (GestaltMatcher) independently confirmed facial asymmetry as a discriminating feature and was part of how the syndrome was delineated. It is an adjunct that can support the oto-facial gestalt in an undiagnosed patient, not a stand-alone diagnostic test - molecular confirmation remains required.
computational facial phenotype analysis NCIT:C18020 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:38386308 SUPPORT Human Clinical
"Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
Documents machine-learning portrait analysis as the method that independently confirmed the discriminating facial feature.
PMID:38386308 SUPPORT Human Clinical
"Clinical characterization included reanalysis of available neuroimaging datasets and 2D portrait image analysis with GestaltMatcher."
Confirms GestaltMatcher 2D portrait analysis as part of the diagnostic characterization workflow.
🩻

Imaging Findings

1
Bilateral Semicircular Canal Dysplasia
MRI-based 3D reconstruction of the inner ear showed bilateral aplasia of the horizontal semicircular canals with dysplasia of the vestibule in one individual and semicircular canal dysplasia in another. No other cerebral anomalies were identified; MRI soft-tissue and bone evaluation additionally revealed a subtle osseous asymmetry of the skull and midface.
Mri Diagnostic Bilateral
semicircular canal UBERON:0001840 Uberon multi-species anatomy ontology (UBERON) Semicircular canal dysplasia HP:0011380 Human Phenotype Ontology (HP)
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
Cranial MRI is the modality that demonstrates the inner ear malformation in this disorder.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
Seven affected individuals from five unrelated families in the original 2024 delineation, with at least one subsequent single-case report. No population prevalence estimate is available.
Show evidence (1 reference)
PMID:38386308 SUPPORT Human Clinical
"We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
The full published cohort at delineation was seven individuals from five families.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Otofacial Neurodevelopmental Syndrome:

CHARGE Syndrome MONDO:0008965
Overlapping Features CHD7-related CHARGE syndrome shares developmental delay, external ear anomalies, semicircular canal hypoplasia or aplasia, and cranial nerve dysfunction with facial palsy, and was the initial clinical impression in several individuals later found to have ZSCAN10 deficiency. In the GestaltMatcher analysis the ZSCAN10 and CHD7 facial clusters partially overlapped, an overlap attributable to shared facial asymmetry.
Distinguishing Features
  • CHARGE syndrome is autosomal dominant and usually caused by de novo CHD7 variants, whereas otofacial neurodevelopmental syndrome is autosomal recessive with bi-allelic ZSCAN10 variants.
  • Coloboma, choanal atresia, and genital hypoplasia with hypogonadotropic hypogonadism are cardinal CHARGE features but are not core features of ZSCAN10 deficiency.
  • Facial asymmetry with unilaterally reduced facial movement is the leading dysmorphic feature of ZSCAN10 deficiency.
Show evidence (1 reference)
PMID:38386308 SUPPORT INDIRECT Human Clinical
"Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
The abstract documents the GestaltMatcher facial-asymmetry analysis that underlies the comparison; the specific partial overlap of the ZSCAN10 and CHD7 clusters and the clinicians' initial consideration of CHARGE syndrome are reported in the paper's Results and discussion, so this is graded INDIRECT.
Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome)
Overlapping Features The combination of asymmetric facial involvement, microtia and other external ear dysplasia, and hearing loss in ZSCAN10 deficiency closely mimics the oculo-auriculo-vertebral (Goldenhar) spectrum; a subsequent report described ZSCAN10 deficiency presenting under that clinical label.
Distinguishing Features
  • Oculo-auriculo-vertebral spectrum is usually sporadic, whereas otofacial neurodevelopmental syndrome is bi-allelic and autosomal recessive.
  • Epibulbar dermoids, hemifacial microsomia with mandibular hypoplasia, and vertebral anomalies characterise oculo-auriculo-vertebral spectrum but are not reported in ZSCAN10 deficiency.
  • Semicircular canal dysplasia and global developmental delay are prominent in ZSCAN10 deficiency; molecular testing is required to distinguish the two.
Show evidence (1 reference)
PMID:40605417 SUPPORT Human Clinical
"ZSCAN10-Deficiency Mimicking Goldenhar Syndrome."
A subsequent clinical report is titled for, and thereby asserts, ZSCAN10 deficiency mimicking Goldenhar syndrome. Only the title is quotable because this letter has no PubMed abstract.
🐁

Animal Models

2
Zscan10 homozygous knockout (Zscan10tm2a(EUCOMM)Wtsi) Mus musculus
Zscan10 knockout mouse embryos were generated and phenotyped by 3D facial morphometry at embryonic day 14.5 and by generalized Procrustes analysis of the reconstructed inner ear. Knockout embryos showed altered symmetric skull shape with reduced relative eye size and ear opening, larger and more fluctuating facial asymmetry than wild-type, and misalignment of a semicircular canal with shortening of the cochlea. Homozygous knockouts showed substantial embryonic lethality, which limited adult phenotyping.
Facial asymmetry Abnormal semicircular canal morphology Abnormality of the outer ear Reduced ear opening Shortened cochlea
Species
Mus musculus
Genotype
Zscan10 homozygous knockout (Zscan10tm2a(EUCOMM)Wtsi)
Background
C57BL/6
Genes
ZSCAN10 hgnc:12997 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns ZSCAN10 (hgnc:12997). hgnc:12997 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:38386308 SUPPORT Model Organism
"Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
The mouse knockout recapitulates the core human oto-facial phenotype.
PMID:38386308 SUPPORT Model Organism
"Zscan10 knockout mouse embryos were generated and phenotyped."
Documents the generation and phenotyping of the Zscan10 knockout mouse embryo model.
Zscan10 homozygous mutant (Kraus et al. allele) Mus musculus
An earlier, independently generated Zscan10 mutant mouse line was systematically phenotyped in the German Mouse Clinic. Homozygous mutants show reduced weight, mild hypoplasia of spleen, heart and long bones, and an eye malformation phenocopying Sox2 hypomorphs. Some of these features (organ and eye malformations) were not observed in the human ZSCAN10 clinical cohort; facial asymmetry and inner ear morphology were not assessed in this model.
Reduced body weight Splenic hypoplasia Cardiac hypoplasia Long bone hypoplasia Eye malformation
Species
Mus musculus
Genotype
Zscan10 homozygous mutant (Kraus et al. allele)
Background
C57BL/6
Genes
ZSCAN10 hgnc:12997 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns ZSCAN10 (hgnc:12997). hgnc:12997 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:25111779 SUPPORT Model Organism
"Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs."
Documents the independent Zscan10 mutant mouse phenotype used for cross-model comparison.
{ }

Source YAML

click to show 
name: Otofacial Neurodevelopmental Syndrome
creation_date: '2026-07-31T00:00:00Z'
category: Mendelian
synonyms:
- ZSCAN10 deficiency
- ZSCAN10-related neurodevelopmental disorder
- ZFP206 deficiency
- Neurodevelopmental disorder with oto-facial malformations
description: >-
  Otofacial neurodevelopmental syndrome is an autosomal recessive syndromic
  neurodevelopmental disorder caused by bi-allelic loss-of-function variants in
  ZSCAN10, which encodes a SCAN-domain C2H2 zinc-finger transcription factor of
  the embryonic stem cell pluripotency network (a direct partner and regulator of
  OCT4/POU5F1 and SOX2). The disorder was delineated in 2024 in seven affected
  individuals from five unrelated families. The consistent clinical triad is
  global developmental delay with mild-to-severe cognitive impairment, facial
  asymmetry (often with unilaterally reduced facial movements or hypotonic
  facies), and malformations of the outer ear. Cranial MRI demonstrates
  semicircular canal dysplasia or aplasia as the anatomical correlate of
  sensorineural hearing loss. Variable additional features include delayed motor
  development, absent or minimal expressive language, behavioural abnormalities
  with autistic features, downslanted palpebral fissures, prominent epicanthic
  folds, microgenitalia, cleft palate, and cardiac malformation. Because facial
  asymmetry, ear malformation and hearing loss co-occur, the phenotype is
  clinically confusable with CHARGE syndrome and with the oculo-auriculo-vertebral
  (Goldenhar) spectrum.
disease_term:
  preferred_term: otofacial neurodevelopmental syndrome
  term:
    id: MONDO:0975705
    label: otofacial neurodevelopmental syndrome
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    evidence:
    - reference: PMID:38386308
      reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
        oto-facial malformations.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10."
      explanation: Supports classification as a hereditary (bi-allelic Mendelian) genetic
        disorder.
  - classification_value: NEUROLOGIC
    evidence:
    - reference: PMID:38386308
      reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
        oto-facial malformations.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
      explanation: Global developmental delay as a consistent feature supports classification
        as a nervous system / neurodevelopmental disorder.
parents:
- Neurodevelopmental Disorder
- Intellectual Disability
notes: >-
  MONDO:0975705 cross-references OMIM:620910 and carries a causal-gene
  relationship to ZSCAN10 (HGNC:12997). ZSCAN10 is also known as ZFP206/ZNF206
  (OMIM *618365); the older literature on embryonic stem cell pluripotency uses
  the Zfp206 gene symbol. No GeneReviews chapter exists for this disorder (PubMed
  searches for both "ZSCAN10 GeneReviews" and "otofacial GeneReviews" returned no
  results on 2026-07-31), which is expected for a condition first delineated in
  2024. Evidence-snippet caveat: the delineating paper (PMID:38386308) is open
  access in PMC, but the publisher PDF returns HTTP 403 to the reference-cache
  fetcher, so only the abstract is cached and only abstract text is quotable. A
  number of per-individual counts stated in the descriptions below (7/7 outer ear
  malformation, 4/5 hearing impairment, 5/7 speech delay, 2/7 microgenitalia,
  1/7 cleft palate, 1/7 cardiac malformation, 2/2 MRI semicircular canal
  dysplasia) come from Table 1 and the Results text of that paper; the attached
  evidence items therefore quote the abstract and carry directness: INDIRECT
  where the abstract does not itemise the feature, since the quote reaches the
  feature through the cohort-level statement. Consequence for frequency qualifiers:
  where the only citable snippet is the abstract's cohort-methods sentence
  ("Next generation sequencing was performed in seven affected individuals..."),
  which supports neither the disease-phenotype association nor a band, the
  `frequency:` slot is deliberately left unset rather than inferred from the
  uncitable Table 1 count (docs/frequency-evidence-guidelines.md: "When in doubt,
  omit the frequency"). Two phenotypes retain a band that an uncitable Table 1
  count arbitrates, in both cases downward, with the reasoning recorded in the
  evidence explanation: facial asymmetry, where 5/7 (71%) lowers a band that the
  abstract's qualitative wording alone would have overstated; and sensorineural
  hearing loss, where the cohort denominator (4/7, 57%) is preferred over the
  assessed-only denominator (4/5, 80%) because the unassessed individuals are of
  unknown rather than known-negative status. Both differ from the seven
  frequency-less phenotypes above in that their snippets do establish the
  disease-phenotype association and only the band is Table 1-derived. PMC full text
  is not retrievable through the sanctioned fetcher (`PMC:` is not a supported
  reference type), so these counts cannot be promoted to quotable snippets
  without hand-editing the reference cache, which is prohibited.
references:
- reference: PMID:38386308
  title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
    oto-facial malformations.
- reference: PMID:41191133
  title: 'Neurogenetic Disorders with Hearing Loss: Mechanisms, Classifications, and
    Emerging Insights.'
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    All reported affected individuals carry bi-allelic (homozygous or compound
    heterozygous) ZSCAN10 protein-truncating variants, with full co-segregation
    in tested family members and no homozygous ZSCAN10 protein-truncating
    variants in gnomAD. Several families originate from consanguineous or
    geographically neighbouring Iranian and Pakistani populations sharing a
    common founder allele.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
    explanation: Bi-allelic variants in multiple unrelated families establish autosomal
      recessive inheritance.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10."
    explanation: The paper's conclusion states the bi-allelic loss-of-function basis
      of the disorder.
pathophysiology:
- name: ZSCAN10 Bi-allelic Loss of Function
  description: >-
    Bi-allelic protein-truncating variants in ZSCAN10 remove the function of a
    SCAN-domain C2H2 zinc-finger transcription factor. All four reported disease
    alleles are protein-truncating variants located in the large terminal exon 6,
    which encodes 66% of the protein including all 14 C2H2 zinc-finger motifs.
    Truncating alleles here are predicted to escape nonsense-mediated decay only
    partially; any translated product lacks a variable fraction of the
    zinc-finger array.
  biological_scale: MOLECULAR
  genes:
  - preferred_term: ZSCAN10
    term:
      id: hgnc:12997
      label: ZSCAN10
  molecular_functions:
  - preferred_term: DNA-binding transcription factor activity
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    modifier: DECREASED
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
    explanation: Human genetic evidence establishes bi-allelic ZSCAN10 loss of function
      as the molecular cause.
  - reference: PMID:16971461
    reference_title: Zfp206 regulates ES cell gene expression and differentiation.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "the putative SCAN-Zinc finger transcription factor Zfp206 is expressed specifically in ES cells"
    explanation: Establishes ZSCAN10/Zfp206 as a SCAN-zinc-finger transcription factor
      of embryonic stem cells.
  downstream:
  - target: Mislocalization and Loss of Enhancer Binding
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:38386308
      reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
        oto-facial malformations.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "we established in mESCs the loss-of-function mechanism for a representative human ZSCAN10 protein truncating variant by showing alteration of its expression levels and subcellular localization, interfering with its binding to DNA enhancer targets."
      explanation: Cell-based modelling links a representative truncating allele directly
        to mislocalization and loss of DNA target binding.
- name: Mislocalization and Loss of Enhancer Binding
  description: >-
    The recurrent human p.(Gln486*) truncating variant, modelled in mouse
    embryonic stem cells, alters ZSCAN10 expression level and shifts the protein
    from a predominantly nuclear to a predominantly cytoplasmic distribution.
    The truncated protein loses binding at ZSCAN10 DNA enhancer and promoter
    targets, including the POU5F1 (Oct4) promoter, providing the molecular
    loss-of-function mechanism.
  biological_scale: MOLECULAR
  genes:
  - preferred_term: ZSCAN10
    term:
      id: hgnc:12997
      label: ZSCAN10
  cellular_components:
  - preferred_term: nucleus
    term:
      id: GO:0005634
      label: nucleus
    modifier: DECREASED
  molecular_functions:
  - preferred_term: DNA-binding transcription factor activity
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: protein import into nucleus
    term:
      id: GO:0006606
      label: protein import into nucleus
    modifier: DECREASED
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we established in mESCs the loss-of-function mechanism for a representative human ZSCAN10 protein truncating variant by showing alteration of its expression levels and subcellular localization, interfering with its binding to DNA enhancer targets."
    explanation: Directly documents altered subcellular localization and loss of enhancer
      binding for the truncating variant.
  - reference: PMID:19740739
    reference_title: Zfp206, Oct4, and Sox2 are integrated components of a transcriptional
      regulatory network in embryonic stem cells.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We show that Zfp206 binds to the Oct4 promoter and directly regulates Oct4 expression."
    explanation: Independently establishes the POU5F1/Oct4 promoter as a direct ZSCAN10
      binding target whose occupancy is lost in the mutant.
  downstream:
  - target: Dysregulation of the Pluripotency Transcriptional Network
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:38386308
      reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with
        characteristic oto-facial malformations.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "RNA-sequencing analyses in Zscan10-/- mESCs indicated dysregulation of genes related to stem cell pluripotency."
      explanation: Loss of ZSCAN10 target binding is accompanied by transcriptome-wide
        dysregulation of pluripotency genes.
- name: Dysregulation of the Pluripotency Transcriptional Network
  description: >-
    ZSCAN10 is an integrated component of the core OCT4/SOX2/NANOG pluripotency
    network and binds more than 3000 target genes in embryonic stem cells. Its
    loss dysregulates genes governing stem cell pluripotency and differentiation
    (including Pou5f1, Sall4, Mtf2, Hoxb13 and Meis2 in knockout mouse embryonic
    stem cells), shifting the balance between progenitor maintenance and fate
    commitment during early embryogenesis. This node is the least certain step in
    the chain: an independent inducible-knockout study found Zscan10-null mouse
    embryonic stem cells to be fully self-renewing and pluripotent, so ZSCAN10 is
    probably not strictly required for baseline pluripotency maintenance. The
    disease-relevant defect may instead lie in progenitor fate choice during
    later embryogenesis rather than in the pluripotent state itself.
  biological_scale: CELLULAR
  mechanism_confidence: HYPOTHETICAL
  cell_types:
  - preferred_term: embryonic stem cell
    term:
      id: CL:0002322
      label: embryonic stem cell
  biological_processes:
  - preferred_term: stem cell population maintenance
    term:
      id: GO:0019827
      label: stem cell population maintenance
    modifier: ABNORMAL
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "RNA-sequencing analyses in Zscan10-/- mESCs indicated dysregulation of genes related to stem cell pluripotency."
    explanation: Knockout embryonic stem cells show dysregulation of the pluripotency
      gene programme.
  - reference: PMID:19740739
    reference_title: Zfp206, Oct4, and Sox2 are integrated components of a transcriptional
      regulatory network in embryonic stem cells.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Genome-wide mapping of Zfp206-binding sites in ESC identifies more than 3000 target genes, many of which encode transcription factors that are also targeted for regulation by Oct4 and Sox2."
    explanation: Establishes the breadth of the ZSCAN10 target network and its overlap
      with OCT4/SOX2.
  - reference: PMID:17628018
    reference_title: Zfp206 is a transcription factor that controls pluripotency of
      embryonic stem cells.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We found that Zfp206 was able to enhance expression from its own promoter and also activate transcription of the Oct4 and Nanog promoters."
    explanation: ZSCAN10 transactivates the OCT4 and NANOG promoters, so its loss removes
      positive drive on the pluripotency network.
  - reference: PMID:17344211
    reference_title: Oct4 and Sox2 directly regulate expression of another pluripotency
      transcription factor, Zfp206, in embryonic stem cells.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We have demonstrated here that Zfp206 is a direct downstream target of Oct4 and Sox2."
    explanation: ZSCAN10 is itself a direct OCT4/SOX2 target, placing it inside a
      reciprocal regulatory loop rather than merely upstream of the network.
  - reference: PMID:25111779
    reference_title: Pleiotropic functions for transcription factor zscan10.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here we suggest a potential role of Zscan10 in controlling progenitor cell populations in vivo."
    explanation: In vivo mouse data extend the embryonic-stem-cell role of ZSCAN10 to
      control of progenitor cell populations.
  - reference: PMID:26592664
    reference_title: Zscan10 is dispensable for maintenance of pluripotency in mouse
      embryonic stem cells.
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "Our results clearly indicate that Zscan10 is dispensable for the ability of self-renewal and differentiation in ES cells."
    explanation: An independent inducible-knockout study refutes a strict requirement
      for ZSCAN10 in embryonic stem cell pluripotency maintenance, so this node is
      curated as the least certain step in the mechanistic chain.
  - reference: PMID:26592664
    reference_title: Zscan10 is dispensable for maintenance of pluripotency in mouse
      embryonic stem cells.
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "We succeeded in establishing Zscan10-null ES cells and confirmed their pluripotency by the generation of chimeric embryos."
    explanation: Zscan10-null embryonic stem cells retained pluripotency in a chimera
      assay, arguing against loss of the pluripotent state as the disease mechanism.
  downstream:
  - target: Disturbed Craniofacial and Otic Morphogenesis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - altered progenitor pool maintenance and fate choice during embryogenesis
    - altered downstream developmental transcription factor output
  - target: Impaired Neurodevelopment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - residual postnatal ZSCAN10 expression in brain
- name: Disturbed Craniofacial and Otic Morphogenesis
  description: >-
    Loss of ZSCAN10 transcriptional output perturbs the developmental programmes
    that shape the face and both the external ear and the membranous labyrinth of
    the inner ear. In affected individuals this manifests as facial asymmetry with
    subtle osseous asymmetry of the skull and midface, outer ear dysplasia, and
    semicircular canal dysplasia or aplasia. Zscan10-deficient mouse embryos
    recapitulate the asymmetric facial shape change together with reduced ear
    opening and misalignment of a semicircular canal with cochlear shortening,
    indicating a conserved developmental mechanism.
  biological_scale: TISSUE
  locations:
  - preferred_term: face
    term:
      id: UBERON:0001456
      label: face
  - preferred_term: semicircular canal
    term:
      id: UBERON:0001840
      label: semicircular canal
  - preferred_term: external ear
    term:
      id: UBERON:0001691
      label: external ear
  biological_processes:
  - preferred_term: semicircular canal morphogenesis
    term:
      id: GO:0048752
      label: semicircular canal morphogenesis
    modifier: ABNORMAL
  - preferred_term: outer ear morphogenesis
    term:
      id: GO:0042473
      label: outer ear morphogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: Establishes facial asymmetry and outer ear malformation as consistent
      human features of the disorder.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
    explanation: The Zscan10 mouse model reproduces the facial and ear malformation
      phenotype, supporting a conserved developmental mechanism.
  downstream:
  - target: Facial Asymmetry
    causal_link_type: DIRECT
  - target: Outer Ear Malformation
    causal_link_type: DIRECT
  - target: Inner Ear Labyrinthine Malformation
    causal_link_type: DIRECT
  - target: Cleft Palate
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Inner Ear Labyrinthine Malformation
  description: >-
    Dysplasia or aplasia of the semicircular canals with vestibular dysmorphology
    is demonstrable on cranial MRI and is the structural inner ear correlate of
    the sensorineural hearing loss seen in this disorder. Notably, despite the
    vestibular malformation, vertigo and imbalance were not reported in the
    original cohort.
  biological_scale: TISSUE
  locations:
  - preferred_term: semicircular canal
    term:
      id: UBERON:0001840
      label: semicircular canal
  biological_processes:
  - preferred_term: semicircular canal development
    term:
      id: GO:0060872
      label: semicircular canal development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: Directly states semicircular canal dysplasia as the anatomical correlate
      of the hearing loss.
  downstream:
  - target: Semicircular Canal Dysplasia
    causal_link_type: DIRECT
  - target: Sensorineural Hearing Loss
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:38386308
      reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with
        characteristic oto-facial malformations.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
      explanation: The paper frames the inner ear malformation as the anatomical correlate
        of the sensorineural hearing loss.
- name: Impaired Neurodevelopment
  description: >-
    ZSCAN10 expression falls with developmental age but remains detectable
    postnatally in brain, testis and pituitary gland. Loss of function produces
    global developmental delay with mild-to-severe cognitive impairment, markedly
    delayed motor milestones, delayed or absent expressive language, and
    behavioural abnormalities. Cranial MRI in the reported individuals showed no
    structural cerebral anomaly beyond the inner ear findings, so the cellular
    substrate of the cognitive phenotype remains undefined.
  biological_scale: ORGANISM
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: nervous system development
    term:
      id: GO:0007399
      label: nervous system development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: Global developmental delay is one of the three consistent clinical
      features of the disorder.
  downstream:
  - target: Global Developmental Delay
    causal_link_type: DIRECT
  - target: Intellectual Disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Motor Delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Delayed Speech and Language Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Autistic Behavior
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Aggressive Behavior
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hyperphagia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
phenotypes:
- category: Clinical
  name: Global Developmental Delay
  description: >-
    Global developmental delay is one of the three consistent clinical features
    of the disorder and was present in all reported individuals.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: Deep phenotyping identifies global developmental delay as a consistent
      feature, supporting a very frequent occurrence.
- category: Clinical
  name: Facial Asymmetry
  description: >-
    Facial asymmetry, frequently with unilaterally reduced facial movements or
    hypotonic facies, is a hallmark feature. It was independently confirmed by
    GestaltMatcher 2D portrait analysis in all analysed individuals and was
    recapitulated in Zscan10-deficient mouse embryos.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Facial asymmetry
    term:
      id: HP:0000324
      label: Facial asymmetry
    onset:
      onset_category: CONGENITAL
      notes: Craniofacial patterning defect, apparent from birth.
    clinical_course: STABLE
  diagnostic: true
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
    explanation: Machine-learning portrait analysis confirms facial asymmetry as a
      consistent clinical feature.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      Supports the disease-phenotype association. The band is set to FREQUENT
      (30-79%) rather than VERY_FREQUENT on the strength of the paper's
      per-individual clinical table, which records facial asymmetry in 5 of 7
      affected individuals (71%). The abstract's "consistent clinical features"
      wording is qualitative and does not by itself pin the band; per
      docs/frequency-evidence-guidelines.md a quantified count takes precedence
      over verbal hedging. Table 1 is outside the abstract and therefore not
      directly quotable here (see the entry-level notes on abstract-only
      caching).
- category: Clinical
  name: Unilaterally Reduced Facial Movement
  description: >-
    Facial asymmetry in this disorder is characteristically accompanied by
    unilaterally reduced facial movement (asymmetric crying facies / hypotonic
    facies rather than a complete lower motor neuron palsy). Together with the
    ear malformations this produces the oto-facial gestalt that distinguishes
    ZSCAN10 deficiency, and it is the component that most often prompts an
    initial referral for hemifacial microsomia or Goldenhar syndrome.
  phenotype_term:
    preferred_term: Unilaterally reduced facial movement
    term:
      id: HP:0012799
      label: Unilateral facial palsy
  diagnostic: true
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      The abstract establishes facial asymmetry as a consistent feature; the
      unilaterally reduced facial movement that accompanies it is described in the
      paper's phenotype narrative and clinical table rather than the abstract, so this
      is marked INDIRECT. No frequency band is asserted because no citable count is
      available in the cached abstract.
- category: Clinical
  name: Motor Stereotypy
  description: >-
    Stereotypic movements were recorded as one of the behavioural abnormalities
    in a single affected individual, alongside autistic features and aggression.
  phenotype_term:
    preferred_term: Stereotypic movements
    term:
      id: HP:0000733
      label: Motor stereotypy
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      The abstract establishes only the seven-individual neurodevelopmental cohort; the
      stereotypic movements are recorded in the paper's clinical table and Results text
      rather than the abstract, so this is marked INDIRECT. No frequency band is
      asserted for the same reason.
- category: Clinical
  name: Outer Ear Malformation
  description: >-
    Malformations of the outer ear are a consistent feature and were present in
    every reported individual, either unilaterally or bilaterally. Described
    anomalies include microtia, low-set and posteriorly rotated ears, an
    angulated or overfolded helix, an absent superior crus of the antihelix, small
    ear lobes, and a crumpled ear.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Outer ear malformation
    term:
      id: HP:0000356
      label: Abnormality of the outer ear
    onset:
      onset_category: CONGENITAL
      notes: Structural malformation of the auricle, present from birth.
    clinical_course: STABLE
  diagnostic: true
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: Outer ear malformation is one of the three consistent clinical features
      defining the syndrome.
- category: Clinical
  name: Semicircular Canal Dysplasia
  description: >-
    Bilateral semicircular canal dysplasia, including aplasia of the horizontal
    semicircular canals and dysplasia of the vestibule, was demonstrated by
    cranial MRI in both individuals for whom imaging datasets were available for
    reanalysis. No other cerebral anomalies were identified.
  phenotype_term:
    preferred_term: Semicircular canal dysplasia
    term:
      id: HP:0011380
      label: Abnormal semicircular canal morphology
    onset:
      onset_category: CONGENITAL
      notes: >-
        Developmental malformation of the otic labyrinth, established in utero
        and non-progressive after birth.
    clinical_course: STABLE
  diagnostic: true
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: Directly documents semicircular canal dysplasia on cranial MRI in
      affected individuals.
- category: Clinical
  name: Sensorineural Hearing Loss
  description: >-
    Unilateral or bilateral hearing impairment, up to complete/profound bilateral
    sensorineural hearing loss, was confirmed in four of five individuals in whom
    hearing was assessed. Vertigo and imbalance were not reported despite the
    vestibular malformation.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: >-
      Sensorineural hearing loss is documented as the functional consequence of
      the inner ear malformation. Denominator decision (recorded deliberately,
      not incidental): the paper reports hearing loss in 4 of 5 individuals in
      whom hearing was formally assessed (80%, which would be VERY_FREQUENT) but
      4 of the full 7-individual cohort (57%, FREQUENT). FREQUENT is chosen
      because the two unassessed individuals are of unknown status rather than
      known-unaffected, so the assessed-only denominator would overstate the
      band by conditioning on ascertainment. The abstract snippet quantifies
      neither denominator; both counts come from Table 1 and are therefore not
      directly quotable (see the entry-level notes).
- category: Clinical
  name: Intellectual Disability
  description: >-
    All affected individuals had cognitive impairment, graded mild to severe in
    the study's clinical table; two had severe impairment with no expressive
    language.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      The abstract reports global developmental delay as a consistent feature; the
      mild-to-severe grading of cognitive impairment is given in the paper's Table 1 and
      discussion rather than the abstract, so this is marked INDIRECT.
- category: Clinical
  name: Motor Delay
  description: >-
    Motor development was markedly delayed in all affected individuals, ranging
    from moderate to profound; one individual did not achieve unsupported walking.
  phenotype_term:
    preferred_term: Delay of motor development
    term:
      id: HP:0001270
      label: Motor delay
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      Motor delay is a component of the reported global developmental delay; the
      abstract does not itemise motor milestones separately, so this is marked INDIRECT.
- category: Clinical
  name: Delayed Speech and Language Development
  description: >-
    Delayed or minimal speech development was present in five of seven affected
    individuals, and two individuals did not develop expressive language at all.
  phenotype_term:
    preferred_term: Delayed or absent expressive language
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      Speech delay is a component of the global developmental delay reported by deep
      phenotyping; the abstract does not itemise it, so this is marked INDIRECT.
- category: Clinical
  name: Autistic Behavior
  description: >-
    Behavioural abnormalities are listed among the highly consistent features in
    the study discussion, and included autistic features, aggression, stereotypic
    movements and, in one individual, excessive hyperphagia.
  phenotype_term:
    preferred_term: Behavioural abnormalities with autistic features
    term:
      id: HP:0000729
      label: Autistic behavior
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      The abstract establishes the seven-individual neurodevelopmental cohort; the
      behavioural abnormalities with autistic features are documented in the paper's
      Table 1, Results and discussion rather than the abstract, so this is marked
      INDIRECT.
- category: Clinical
  name: Cleft Palate
  description: >-
    Cleft palate was reported in one of seven affected individuals, and a high
    arched palate in another, indicating variable palatal involvement rather than
    a core feature.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The 1/7 count lives in the paper's Table 1, outside the cached abstract.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Cleft palate is recorded for one of the seven individuals in the study's clinical
      table; the abstract establishes only the seven-individual dysmorphic cohort, so
      this is graded INDIRECT.
- category: Clinical
  name: Micropenis
  description: >-
    Microgenitalia was reported in two of seven affected individuals. The study
    attributes this to residual postnatal ZSCAN10 expression in the testis.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The count (2 of 7 individuals, i.e. 2 of 4 males) is in Table 1, outside the
  # cached abstract; the sex-appropriate denominator would also change the band.
  phenotype_term:
    preferred_term: Microgenitalia
    term:
      id: HP:0000054
      label: Micropenis
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Microgenitalia is recorded for two of the seven individuals in the study's
      clinical table and discussed as a consequence of residual testicular ZSCAN10
      expression; the abstract establishes only the seven-individual cohort, so this is
      graded INDIRECT.
- category: Clinical
  name: Cryptorchidism
  description: >-
    Maldescended testis was reported in one affected male, alongside
    microgenitalia, and is attributed to residual postnatal ZSCAN10 expression in
    the testis.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The 1/7 count lives in the paper's Table 1, outside the cached abstract.
  phenotype_term:
    preferred_term: Maldescended testis
    term:
      id: HP:0000028
      label: Cryptorchidism
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Maldescended testis is recorded for one of the seven individuals in the study's
      clinical table and discussed as a consequence of residual testicular ZSCAN10
      expression; the abstract establishes only the seven-individual cohort, so this is
      graded INDIRECT.
- category: Clinical
  name: Downslanted Palpebral Fissures
  description: >-
    Downslanting palpebral fissures were among the common dysmorphic features
    noted in the majority of affected individuals.
  phenotype_term:
    preferred_term: Down slanting palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Downslanting palpebral fissures are itemised among the common dysmorphic features
      in the study's results text; the abstract only establishes the dysmorphic cohort,
      so this is graded INDIRECT.
- category: Clinical
  name: Epicanthus
  description: >-
    Prominent epicanthic folds were among the common dysmorphic features noted in
    the majority of affected individuals.
  phenotype_term:
    preferred_term: Prominent epicanthic folds
    term:
      id: HP:0000286
      label: Epicanthus
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Prominent epicanthic folds are itemised among the common dysmorphic features in
      the study's results text; the abstract only establishes the dysmorphic cohort, so
      this is graded INDIRECT.
- category: Clinical
  name: Visual Impairment
  description: >-
    Vision impairment was recorded in three of seven affected individuals in the
    study's clinical table (two individuals were scored as unaffected and two were
    not determined). Unlike the Zscan10 mutant mouse, no structural eye
    malformation was reported in the human cohort.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The 3/7 count lives in the paper's Table 1, outside the cached abstract.
  phenotype_term:
    preferred_term: Vision impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Vision impairment is recorded for three of the seven individuals in the study's
      clinical table; the abstract establishes only the seven-individual cohort, so this
      is graded INDIRECT.
- category: Clinical
  name: Cardiac Malformation
  description: >-
    A cardiac malformation was reported in one of seven affected individuals and
    mild left ventricular enlargement in another, making cardiac involvement an
    occasional rather than a core feature.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The 1/7 count lives in the paper's Table 1, outside the cached abstract.
  phenotype_term:
    preferred_term: Cardiac malformation
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Cardiac malformation is recorded for one of the seven individuals in the study's
      clinical table; the abstract establishes only the seven-individual cohort, so this
      is graded INDIRECT.
- category: Clinical
  name: Aggressive Behavior
  description: >-
    Aggression was recorded as a behavioural abnormality in two of seven affected
    individuals, in both cases alongside other behavioural features.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The 2/7 count lives in the paper's Table 1, outside the cached abstract.
  phenotype_term:
    preferred_term: Aggression
    term:
      id: HP:0000718
      label: Aggressive behavior
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Aggression is recorded for two of the seven individuals in the study's clinical
      table; the abstract establishes only the seven-individual cohort, so this is
      graded INDIRECT.
- category: Clinical
  name: Hyperphagia
  description: >-
    One affected individual developed excessive hyperphagia in addition to autistic
    features, a distinctive but so far single-case behavioural finding.
  # frequency intentionally omitted: the only citable snippet is the abstract's
  # cohort-methods sentence, which supports neither the association nor a band.
  # The single-case count lives in the paper's Results, outside the cached abstract.
  phenotype_term:
    preferred_term: Excessive hyperphagia
    term:
      id: HP:0002591
      label: Polyphagia
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: >-
      Excessive hyperphagia is recorded for one of the seven individuals in the study's
      Results text; the abstract establishes only the seven-individual cohort, so this
      is graded INDIRECT.
imaging_findings:
- name: Bilateral Semicircular Canal Dysplasia
  modality: MRI
  description: >-
    MRI-based 3D reconstruction of the inner ear showed bilateral aplasia of the
    horizontal semicircular canals with dysplasia of the vestibule in one
    individual and semicircular canal dysplasia in another. No other cerebral
    anomalies were identified; MRI soft-tissue and bone evaluation additionally
    revealed a subtle osseous asymmetry of the skull and midface.
  laterality: BILATERAL
  located_in:
    preferred_term: semicircular canal
    term:
      id: UBERON:0001840
      label: semicircular canal
  phenotype_term:
    preferred_term: Semicircular canal dysplasia
    term:
      id: HP:0011380
      label: Abnormal semicircular canal morphology
  diagnostic: true
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: Cranial MRI is the modality that demonstrates the inner ear malformation
      in this disorder.
genetic:
- name: ZSCAN10 bi-allelic loss-of-function variants
  association: Causative
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: ZSCAN10
    term:
      id: hgnc:12997
      label: ZSCAN10
  variant_origin: GERMLINE
  notes: >-
    Four unique protein-truncating variants were reported across five families:
    c.1112del p.(Pro371Argfs*49), c.1456C>T p.(Gln486*), c.1250C>A p.(Ser417*) and
    c.2050del p.(His684Thrfs*153) (GenBank NM_032805.3 / NP_116194). All lie in
    the large terminal exon 6. The recurrent c.1456C>T p.(Gln486*) allele was
    homozygous in five affected individuals from Iranian and Pakistani families
    sharing extended runs of homozygosity around the ZSCAN10 locus, consistent
    with a distant shared founder; it is present in gnomAD v2.1.1 only in the
    heterozygous state in the South Asian cohort (minor allele frequency about
    7 x 10^-4). No homozygous ZSCAN10 protein-truncating variants were listed in
    gnomAD v2.1.1. These per-variant details come from Table 1 and the Results
    text of PMID:38386308, which are outside the cached abstract.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
    explanation: Establishes bi-allelic ZSCAN10 loss-of-function variation as causative
      in the reported cohort.
animal_models:
- species: Mus musculus
  genotype: Zscan10 homozygous knockout (Zscan10tm2a(EUCOMM)Wtsi)
  background: C57BL/6
  description: >-
    Zscan10 knockout mouse embryos were generated and phenotyped by 3D facial
    morphometry at embryonic day 14.5 and by generalized Procrustes analysis of
    the reconstructed inner ear. Knockout embryos showed altered symmetric skull
    shape with reduced relative eye size and ear opening, larger and more
    fluctuating facial asymmetry than wild-type, and misalignment of a
    semicircular canal with shortening of the cochlea. Homozygous knockouts showed
    substantial embryonic lethality, which limited adult phenotyping.
  genes:
  - preferred_term: ZSCAN10
    term:
      id: hgnc:12997
      label: ZSCAN10
  associated_phenotypes:
  - Facial asymmetry
  - Abnormal semicircular canal morphology
  - Abnormality of the outer ear
  - Reduced ear opening
  - Shortened cochlea
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
    explanation: The mouse knockout recapitulates the core human oto-facial phenotype.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Zscan10 knockout mouse embryos were generated and phenotyped."
    explanation: Documents the generation and phenotyping of the Zscan10 knockout mouse
      embryo model.
- species: Mus musculus
  genotype: Zscan10 homozygous mutant (Kraus et al. allele)
  background: C57BL/6
  description: >-
    An earlier, independently generated Zscan10 mutant mouse line was
    systematically phenotyped in the German Mouse Clinic. Homozygous mutants show
    reduced weight, mild hypoplasia of spleen, heart and long bones, and an eye
    malformation phenocopying Sox2 hypomorphs. Some of these features (organ and
    eye malformations) were not observed in the human ZSCAN10 clinical cohort;
    facial asymmetry and inner ear morphology were not assessed in this model.
  genes:
  - preferred_term: ZSCAN10
    term:
      id: hgnc:12997
      label: ZSCAN10
  associated_phenotypes:
  - Reduced body weight
  - Splenic hypoplasia
  - Cardiac hypoplasia
  - Long bone hypoplasia
  - Eye malformation
  evidence:
  - reference: PMID:25111779
    reference_title: Pleiotropic functions for transcription factor zscan10.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs."
    explanation: Documents the independent Zscan10 mutant mouse phenotype used for
      cross-model comparison.
differential_diagnoses:
- name: CHARGE Syndrome
  description: >-
    CHD7-related CHARGE syndrome shares developmental delay, external ear
    anomalies, semicircular canal hypoplasia or aplasia, and cranial nerve
    dysfunction with facial palsy, and was the initial clinical impression in
    several individuals later found to have ZSCAN10 deficiency. In the
    GestaltMatcher analysis the ZSCAN10 and CHD7 facial clusters partially
    overlapped, an overlap attributable to shared facial asymmetry.
  disease_term:
    preferred_term: CHARGE syndrome
    term:
      id: MONDO:0008965
      label: CHARGE syndrome
  distinguishing_features:
  - CHARGE syndrome is autosomal dominant and usually caused by de novo CHD7 variants,
    whereas otofacial neurodevelopmental syndrome is autosomal recessive with bi-allelic
    ZSCAN10 variants.
  - Coloboma, choanal atresia, and genital hypoplasia with hypogonadotropic hypogonadism
    are cardinal CHARGE features but are not core features of ZSCAN10 deficiency.
  - Facial asymmetry with unilaterally reduced facial movement is the leading dysmorphic
    feature of ZSCAN10 deficiency.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
    explanation: >-
      The abstract documents the GestaltMatcher facial-asymmetry analysis that underlies
      the comparison; the specific partial overlap of the ZSCAN10 and CHD7 clusters and
      the clinicians' initial consideration of CHARGE syndrome are reported in the
      paper's Results and discussion, so this is graded INDIRECT.
- name: Oculo-Auriculo-Vertebral Spectrum (Goldenhar Syndrome)
  description: >-
    The combination of asymmetric facial involvement, microtia and other external
    ear dysplasia, and hearing loss in ZSCAN10 deficiency closely mimics the
    oculo-auriculo-vertebral (Goldenhar) spectrum; a subsequent report described
    ZSCAN10 deficiency presenting under that clinical label.
  distinguishing_features:
  - Oculo-auriculo-vertebral spectrum is usually sporadic, whereas otofacial neurodevelopmental
    syndrome is bi-allelic and autosomal recessive.
  - Epibulbar dermoids, hemifacial microsomia with mandibular hypoplasia, and vertebral
    anomalies characterise oculo-auriculo-vertebral spectrum but are not reported in
    ZSCAN10 deficiency.
  - Semicircular canal dysplasia and global developmental delay are prominent in ZSCAN10
    deficiency; molecular testing is required to distinguish the two.
  evidence:
  - reference: PMID:40605417
    reference_title: ZSCAN10-Deficiency Mimicking Goldenhar Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ZSCAN10-Deficiency Mimicking Goldenhar Syndrome."
    explanation: A subsequent clinical report is titled for, and thereby asserts, ZSCAN10
      deficiency mimicking Goldenhar syndrome. Only the title is quotable because this
      letter has no PubMed abstract.
diagnosis:
- name: Molecular confirmation by exome or genome sequencing
  description: >-
    The diagnosis is established by identifying bi-allelic (homozygous or
    compound heterozygous) loss-of-function variants in ZSCAN10. Trio exome or
    genome sequencing is the practical first-line test, since the phenotype was
    delineated by next-generation sequencing rather than by a pre-existing
    clinical gestalt. Phase must be confirmed - the two variants have to be
    demonstrated in trans, by parental testing where parents are available.
    Consanguinity or South Asian ancestry raises the prior probability of a
    homozygous founder allele.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  results: >-
    Two pathogenic or likely pathogenic ZSCAN10 loss-of-function alleles in trans
    establish the molecular diagnosis.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
    explanation: Directly establishes bi-allelic ZSCAN10 loss of function as the diagnostic
      molecular finding.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features."
    explanation: Confirms next-generation sequencing as the diagnostic modality that
      identified the cohort.
- name: Audiological assessment
  description: >-
    Because sensorineural hearing loss is a core feature and the ear
    malformations are present from birth, formal audiological testing is
    indicated at diagnosis and on follow-up. Age-appropriate testing includes
    otoacoustic emissions and auditory brainstem response in infants and
    pure-tone audiometry in older children. Hearing loss ranged from unilateral
    impairment to profound bilateral loss in the reported cohort, so a normal
    newborn screen on one side does not exclude the diagnosis.
  diagnosis_term:
    preferred_term: audiological assessment
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  markers: Otoacoustic emissions, auditory brainstem response, pure-tone audiometry
  results: >-
    Uni- or bilateral sensorineural hearing loss, up to profound bilateral loss.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: >-
      Establishes the sensorineural hearing loss that makes audiological assessment
      necessary. The specific test battery is standard audiological practice rather than
      a protocol stated in this paper, so this is graded INDIRECT.
- name: Temporal bone and cerebral MRI
  description: >-
    High-resolution imaging of the inner ear is the single most discriminating
    investigation. Cerebral MRI with dedicated temporal bone sequences (or
    high-resolution CT) demonstrates dysplasia or aplasia of the semicircular
    canals and vestibular dysplasia. In the reported cohort no other cerebral
    anomaly was found, so an otherwise normal brain MRI with isolated
    labyrinthine malformation is the expected pattern and should raise ZSCAN10
    deficiency in a child with developmental delay and ear anomalies.
  diagnosis_term:
    preferred_term: magnetic resonance imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  results: >-
    Dysplasia or aplasia of the semicircular canals with vestibular dysplasia,
    typically without other cerebral malformation.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: Directly documents the diagnostic imaging finding and the modality
      that demonstrates it.
- name: Computational facial gestalt analysis
  description: >-
    Automated 2D portrait analysis (GestaltMatcher) independently confirmed
    facial asymmetry as a discriminating feature and was part of how the
    syndrome was delineated. It is an adjunct that can support the oto-facial
    gestalt in an undiagnosed patient, not a stand-alone diagnostic test -
    molecular confirmation remains required.
  diagnosis_term:
    preferred_term: computational facial phenotype analysis
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations."
    explanation: Documents machine-learning portrait analysis as the method that independently
      confirmed the discriminating facial feature.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical characterization included reanalysis of available neuroimaging datasets and 2D portrait image analysis with GestaltMatcher."
    explanation: Confirms GestaltMatcher 2D portrait analysis as part of the diagnostic
      characterization workflow.
treatments:
- name: Cochlear Implantation
  description: >-
    For profound bilateral sensorineural hearing loss, cochlear implantation
    bypasses the failed cochlear transduction by stimulating the auditory nerve
    directly. Candidacy assessment in this disorder is not routine: the
    labyrinthine malformation that causes the hearing loss also alters implant
    anatomy, so dedicated temporal bone imaging must precede implantation to
    define the cochlear lumen, the course of the facial nerve, and the risk of a
    perilymph gusher associated with vestibular and semicircular canal
    dysplasia. Malformed cochleae remain implantable, but electrode choice,
    surgical approach and counselling about expected outcome all depend on the
    imaging.
  context: Profound bilateral sensorineural hearing loss with documented labyrinthine anatomy
  action_category: THERAPEUTIC
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  target_mechanisms:
  - target: Inner Ear Labyrinthine Malformation
    treatment_effect: BYPASSES
    description: >-
      A cochlear implant does not correct the developmental labyrinthine
      malformation; it works around the resulting transduction failure by
      delivering electrical stimulation directly to the auditory nerve. The same
      malformation constrains how the device can be placed, which is why implant
      candidacy in this disorder is anatomy-dependent.
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  notes: >-
    Inferred from the reported phenotype (uni- or bilateral hearing impairment up
    to profound bilateral sensorineural hearing loss) together with the
    documented semicircular canal and vestibular dysplasia. No implantation
    outcome has been reported in a ZSCAN10-deficient individual, and no
    GeneReviews chapter exists, so the anatomy-dependent candidacy caveat is
    general otological practice applied to this disorder's imaging phenotype
    rather than disorder-specific published guidance.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss."
    explanation: >-
      Establishes the sensorineural hearing loss that motivates audiological management;
      the paper reports no treatment data, so this is graded INDIRECT.
  - reference: PMID:41191133
    reference_title: 'Neurogenetic Disorders with Hearing Loss: Mechanisms, Classifications,
      and Emerging Insights.'
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: "hearing loss can serve as an early marker of systemic neurogenetic disease that may offer a window of opportunity for timely intervention"
    explanation: >-
      A 2025 review of neurogenetic disorders with hearing loss supports early
      audiological identification and intervention as the management rationale. It is a
      narrative review covering 38 genes and does not name ZSCAN10 in its abstract, so
      this supports the general framing only and is graded INDIRECT.
- name: Hearing Amplification
  description: >-
    For the unilateral and non-profound bilateral hearing loss that made up most
    of the reported cohort, conventional amplification is the first-line
    rehabilitation. Because the loss is congenital and coexists with global
    developmental delay and expressive language delay, early fitting matters
    disproportionately here - untreated hearing loss compounds the language
    delay that is already part of the syndrome.
  context: Unilateral or non-profound bilateral sensorineural hearing loss
  action_category: THERAPEUTIC
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: hearing amplification
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: hearing aid
        term:
          id: NCIT:C183182
          label: Hearing Aid
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  notes: >-
    Inferred standard-of-care for congenital sensorineural hearing loss; no
    disorder-specific amplification study exists for ZSCAN10 deficiency.
  evidence:
  - reference: PMID:41191133
    reference_title: 'Neurogenetic Disorders with Hearing Loss: Mechanisms, Classifications,
      and Emerging Insights.'
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: "hearing loss can serve as an early marker of systemic neurogenetic disease that may offer a window of opportunity for timely intervention"
    explanation: >-
      Supports early identification and intervention for hearing loss in neurogenetic
      disease as the rationale for prompt amplification. The review does not name
      ZSCAN10 in its abstract, so this supports the general framing only and is marked
      as INDIRECT.
- name: Developmental and Educational Support
  description: >-
    Early intervention with physical, occupational and speech-language therapy is
    indicated for the global developmental delay, motor delay and delayed or
    absent expressive language. Augmentative and alternative communication should
    be considered for individuals without expressive language, particularly where
    hearing loss compounds the language delay.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  notes: >-
    Inferred standard-of-care for syndromic developmental delay; no
    disorder-specific intervention study exists.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: >-
      Establishes the developmental delay that motivates early intervention; the paper
      reports no treatment data, so this is graded INDIRECT.
- name: Genetic Counseling
  description: >-
    Autosomal recessive inheritance implies a 25% recurrence risk for siblings.
    Several reported families were consanguineous or shared a founder allele
    present in South Asian populations, making carrier testing and counselling
    relevant for at-risk relatives.
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  notes: >-
    Standard counselling implication of the established autosomal recessive
    mechanism.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10."
    explanation: The established bi-allelic (autosomal recessive) mechanism is what
      grounds recurrence-risk counselling.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Seven affected individuals from five unrelated families in the original 2024
    delineation, with at least one subsequent single-case report. No population
    prevalence estimate is available.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause."
    explanation: The full published cohort at delineation was seven individuals from
      five families.
discussions:
- discussion_id: zscan10_pluripotency_to_craniofacial_gap
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    How does loss of a transcription factor whose best-characterized role is
    maintenance of embryonic stem cell pluripotency produce a spatially specific
    oto-facial malformation phenotype rather than a global embryonic defect?
  attaches_to:
  - pathophysiology#Dysregulation of the Pluripotency Transcriptional Network
  - pathophysiology#Disturbed Craniofacial and Otic Morphogenesis
  rationale: >-
    ZSCAN10 expression is highest in embryonic stem cells and falls sharply with
    differentiation, yet the human phenotype is dominated by asymmetric
    craniofacial and otic malformations. The intervening cell populations
    (plausibly cranial neural crest and otic placode derivatives) and the
    developmental window in which ZSCAN10 loss becomes consequential have not been
    identified, which is why the causal edge from network dysregulation to
    craniofacial morphogenesis is curated with unknown intermediates.
  evidence:
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "RNA-sequencing analyses in Zscan10-/- mESCs indicated dysregulation of genes related to stem cell pluripotency."
    explanation: The only mechanistic readout available is in the pluripotent state,
      which is precisely why the step from there to the craniofacial phenotype is a gap.
  - reference: PMID:38386308
    reference_title: ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic
      oto-facial malformations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep phenotyping revealed global developmental delay, facial asymmetry and malformations of the outer ear as consistent clinical features."
    explanation: The spatially restricted oto-facial human phenotype is what the
      pluripotency-network readout does not explain.
  proposed_experiments:
  - experiment_id: zscan10_lineage_scrnaseq
    name: Lineage-resolved single-cell transcriptomics of Zscan10-null embryos
    description: >-
      Single-cell RNA-seq of Zscan10-/- and wild-type mouse embryos sampled across
      the otic placode and cranial neural crest stages, to identify which lineage
      first diverges transcriptionally.
    decision_criterion: >-
      A lineage showing significant divergence before overt morphological
      abnormality identifies the primary affected progenitor population.
  - experiment_id: zscan10_conditional_deletion
    name: Conditional tissue-restricted Zscan10 deletion
    description: >-
      Conditional Zscan10 deletion restricted to cranial neural crest or to otic
      epithelium, to test whether the malformation is cell-autonomous to either
      lineage.
    decision_criterion: >-
      Reproduction of the oto-facial malformation by a tissue-restricted deletion
      demonstrates a cell-autonomous requirement in that lineage.
  - experiment_id: zscan10_stage_specific_chipseq
    name: Stage-specific ZSCAN10 enhancer mapping
    description: >-
      ZSCAN10 ChIP-seq in human neural crest and otic organoid models to identify
      stage-specific enhancer targets beyond the pluripotency network.
    decision_criterion: >-
      Identification of craniofacial or otic developmental enhancers bound by
      ZSCAN10 outside the pluripotent state would supply the missing intermediate.
- discussion_id: zscan10_mouse_human_phenotype_mismatch
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Do the extra-craniofacial phenotypes of Zscan10 mutant mice (organ and eye
    malformations, reduced weight, spleen, heart and long bone hypoplasia) have
    human counterparts, or is the mouse model over-reporting relative to human
    ZSCAN10 deficiency?
  attaches_to:
  - pathophysiology#Disturbed Craniofacial and Otic Morphogenesis
  rationale: >-
    The earlier Zscan10 mutant mouse line shows reduced weight, mild spleen, heart
    and long bone hypoplasia, and a Sox2-hypomorph-like eye malformation. The
    original human study explicitly notes that these organ and eye malformations
    were not observed in its clinical cohort, while the facial and ear findings
    were strikingly concordant. With only seven reported individuals, absence of
    the extra-craniofacial features in humans may reflect ascertainment and cohort
    size rather than true species divergence. In addition, high embryonic lethality
    of the homozygous knockout in the newer line precluded adult mouse phenotyping,
    limiting comparison to the postnatal human phenotype.
  proposed_experiments:
  - experiment_id: zscan10_expanded_cohort_multisystem
    name: Systematic multisystem assessment of an expanded human cohort
    description: >-
      Systematic ophthalmological, splenic, cardiac and skeletal assessment in an
      expanded human ZSCAN10 cohort assembled through GeneMatcher.
    decision_criterion: >-
      Detection of eye or visceral hypoplasia at above-background frequency in a
      larger human cohort would resolve the apparent mismatch as ascertainment.
  - experiment_id: zscan10_adult_mouse_phenotyping
    name: Postnatal phenotyping of surviving Zscan10 mutant mice
    description: >-
      Deep phenotyping of surviving adult Zscan10 mutant mice on a permissive
      genetic background, including facial morphometry and inner ear imaging not
      performed in the original German Mouse Clinic pipeline.
    decision_criterion: >-
      Concordance of adult mouse and human postnatal phenotypes would establish
      the model's translational validity beyond the embryonic stage.
  evidence:
  - reference: PMID:25111779
    reference_title: Pleiotropic functions for transcription factor zscan10.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs."
    explanation: Documents the mouse phenotypes whose human counterparts are uncertain.
📚

References & Deep Research

References

2
PMID:38386308
ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations.
No top-level findings curated for this source.
PMID:41191133
Neurogenetic Disorders with Hearing Loss: Mechanisms, Classifications, and Emerging Insights.
No top-level findings curated for this source.

Deep Research

2
Claude Code ▸
Otofacial Neurodevelopmental Syndrome (OFNS) — Comprehensive Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 14 citations 2026-07-31T17:21:34.726687

Otofacial Neurodevelopmental Syndrome (OFNS) — Comprehensive Research Report

1. Disease Information

Overview. Otofacial neurodevelopmental syndrome (OFNS) is a recently delineated (2024), rare, autosomal recessive neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10. It is characterized by the triad of (1) global developmental delay/intellectual disability, (2) variable facial asymmetry with hypotonic/dysmorphic facies, and (3) outer and inner ear malformations causing sensorineural hearing impairment. The condition was first described in a 2024 Brain paper by Laugwitz et al., "ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations" (PMID: 38386308), based on 7 affected individuals from 5 unrelated families.

Key identifiers: | Resource | ID | |---|---| | OMIM (phenotype) | #620910 — OTOFACIAL NEURODEVELOPMENTAL SYNDROME; OFNS | | OMIM (gene) | *618365 — ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10 | | MONDO | MONDO:0975705 | | MedGen | UID 1857968 / UMLS C5935642 | | HGNC gene symbol | ZSCAN10 (formerly ZNF206) | | NCBI Gene ID (human) | 84891 | | Ensembl gene | ENSG00000130182 (chr16:3,088,890–3,099,295, GRCh38) | | Orphanet / ICD-10/11 | Not yet assigned as of this writing — the disorder is too recently described (2024) to have an Orphanet or ICD entry; not found in Orphanet or WHO ICD searches during this research |

Synonyms: OFNS; ZSCAN10 deficiency; ZSCAN10-related neurodevelopmental disorder.

Evidence basis: All currently available clinical information derives from a single aggregated case-series publication (7 patients, 5 families) plus corroborating mouse and cell-line (mESC) functional data — this is an aggregated disease-level literature resource, not an EHR-derived cohort. There is no disease registry, natural-history study, or additional independent case series published yet (as of the July 2026 literature search performed for this report).

2. Etiology

Disease causal factor: OFNS is a monogenic disease caused by bi-allelic (homozygous or compound heterozygous) protein-truncating (loss-of-function) variants in ZSCAN10 (chromosome 16p13.3). No environmental, infectious, or multifactorial causal contribution has been reported — it is a purely Mendelian, single-gene neurodevelopmental disorder.

Genetic risk factors: - All 5 families' variants are protein-truncating variants (PTVs) clustered in the terminal coding exon (exon 6), which encodes 66% of the protein (518/780 amino acids) including 13–14 of the 14 C2H2 zinc-finger DNA-binding motifs. - Variants identified (PMID:38386308): - c.1456C>T, p.Gln486 — homozygous in families F2, F4, F5 (5 individuals); population allele frequency ~7×10⁻⁴ in gnomAD South Asian subpopulation (17 heterozygotes; no homozygous PTVs observed in gnomAD v2.1.1), consistent with a possible South Asian founder allele. - c.1112del, p.Pro371Argfs49 — homozygous in family F1. - c.1250C>A, p.Ser417 and c.2050del, p.His684Thrfs153 — compound heterozygous in family F3. - Founder effect: Families F2 and F5 shared runs of homozygosity (2.5–8.1 Mb) around the c.1456C>T allele, suggesting a shared ancestral haplotype in individuals of South/West Asian origin (Turkish, Iranian, Indian, Pakistani). - Consanguinity: Consistent with autosomal recessive inheritance and the predominantly consanguineous/endogamous populations sampled (Turkey, Iran, India, Pakistan). - Because all reported variants escape nonsense-mediated decay (they lie downstream of the last exon-junction complex), the mechanism is truncated-protein production with loss/mislocalization of function, not simple haploinsufficiency via mRNA degradation.

Protective factors: None reported; no protective variants or modifier alleles have been described for ZSCAN10-related disease.

Gene-environment interactions: None reported; no environmental modifiers of expressivity have been studied given the extreme rarity and recency of the disorder's description.

3. Phenotypes

All phenotype data below is drawn from the 7-patient cohort in Laugwitz et al. 2024 (PMID:38386308).

Phenotype (clinical) Frequency Suggested HPO term Notes
Global developmental delay 7/7 HP:0001263 (Global developmental delay) Present in all patients; core feature
Intellectual disability 7/7 HP:0001249 (Intellectual disability) Ranges mild to severe/profound
Delayed/absent speech 5/7 delayed; 2/7 no expressive language HP:0000750 (Delayed speech and language development) Variable severity
Motor delay 7/7 HP:0001270 (Motor delay) Variable severity
Facial asymmetry 5/7 HP:0000324 (Facial asymmetry) Core distinguishing feature; validated computationally via GestaltMatcher (82% classification accuracy for asymmetry)
Hypotonic facies Variable HP:0000308 (Microretrognathia)-adjacent / HP:0000426 (Limited facial movement) Unilaterally reduced facial movement described
Outer ear malformation 7/7 HP:0031703 (Abnormal external ear morphology) Bilateral (5/7) or unilateral (2/7); low-set, posteriorly rotated, microtia, absent superior crus of antihelix
Microtia Subset HP:0008551 (Microtia)
Low-set ears Subset HP:0000369 (Low-set ears)
Posteriorly rotated ears Subset HP:0000358 (Posteriorly rotated ears)
Inner ear/semicircular canal dysplasia 2/2 tested (MRI) HP:0011387 (Abnormal semicircular canal morphology) Bilateral in both imaged patients
Sensorineural hearing loss 4/5 tested HP:0000407 (Sensorineural hearing impairment) Unilateral deafness to profound bilateral loss
Behavioral abnormalities 3/7 — Autistic features (2), aggression (2), stereotypic movements (1), hyperphagia (1)
Autistic behavior 2/7 HP:0000729 (Autistic behavior)
Aggressive behavior 2/7 HP:0000718 (Aggressive behavior)
Stereotypy 1/7 HP:0000733 (Stereotypy)
Hyperphagia 1/7 HP:0002591 (Polyphagia)
Visual impairment 3/7 HP:0000505 (Visual impairment)
Micropenis 2/4 males HP:0000054 (Micropenis)
Maldescended testis Subset of the above HP:0000028 (Cryptorchidism)
Cardiac defect (mild LV enlargement) 1/7 HP:0001627 (Abnormal heart morphology)
Cleft palate 1/7 HP:0000175 (Cleft palate)
Down-slanting palpebral fissures Variable HP:0000494 (Downslanted palpebral fissures)
Prominent epicanthic folds Variable HP:0000286 (Epicanthus)

Onset: Congenital/present from birth (ear malformations, facial asymmetry evident perinatally); developmental delay recognized in infancy/early childhood. Severity/progression: Non-progressive, static congenital malformation plus a stable-to-slowly-clarifying developmental delay course (typical of a structural/transcription-factor neurodevelopmental disorder rather than a degenerative one); severity is variable across the cognitive spectrum (mild to profound). Quality of life impact: Not formally measured (no EQ-5D/SF-36/PROMIS data reported); qualitatively, hearing loss and developmental delay are expected to impact communication, education, and adaptive functioning; behavioral features (aggression, autistic traits) may affect social functioning. No disease-specific QOL instrument exists yet given the 2024 initial description.

4. Genetic/Molecular Information

Causal gene: ZSCAN10 (Zinc Finger and SCAN Domain Containing 10; alias ZNF206), HGNC-approved symbol ZSCAN10, NCBI Gene ID 84891, located at 16p13.3 (OMIM *618365).

Variant classification/type: All four distinct variants identified to date are protein-truncating variants (PTVs) — one frameshift deletion pair and two nonsense (stop-gain) variants — clustered in the final coding exon (exon 6). Per ACMG/AMP framework these would be classified pathogenic/likely pathogenic on the basis of: PVS1-adjacent truncating location within a critical functional domain (loss of 13–14 zinc fingers), absence of homozygotes in population databases, full co-segregation with phenotype in available family members, and functional validation (mislocalization + loss of DNA binding).

Population allele frequency: The recurrent c.1456C>T (p.Gln486) allele occurs at ~7×10⁻⁴ in the gnomAD South Asian subpopulation (17 heterozygous carriers, v2.1.1), with zero homozygous PTV carriers* reported in gnomAD generally — consistent with a rare recessive disease allele under purifying selection against the homozygous state, and with a South/West Asian founder effect.

Somatic vs. germline: All variants reported are germline, inherited in autosomal recessive fashion; no somatic mosaicism reported.

Functional consequences (loss of function): - Wild-type ZSCAN10 protein localizes to the nucleus; the truncated mutant protein (e.g., ZSCAN10^485 from c.1456C>T) is instead mainly cytoplasmic — i.e., the truncation disrupts nuclear import/localization. - ChIP-qPCR shows the mutant protein loses DNA-binding capacity at the POU5F1 (OCT4) promoter, a direct ZSCAN10 target, versus strong wild-type binding. - RNA-seq in Zscan10⁻/⁻ mouse embryonic stem cells (mESCs) shows 1,310 differentially expressed genes (710 down, 600 up; FDR<0.05), including dysregulation of pluripotency/developmental genes Pou5f1, Sall4, Mtf2, Hoxb13, Meis2. KEGG pathway analysis flagged "ATP-dependent chromatin remodeling" as the top affected pathway among downregulated genes. - Direct quote (PMID:38386308): "Loss of ZSCAN10 function is the likely consequence and pathomechanism of the identified disease alleles" and "Loss of ZSCAN10 dysregulates several genes associated with pluripotency and differentiation of ESCs."

Modifier genes: None identified/reported.

Epigenetic information: No disease-specific DNA methylation, histone modification, or chromatin-mark studies have been reported in patients; the mechanistic link is via ZSCAN10's role as a transcriptional/chromatin-remodeling regulator rather than via an epigenetic mark on the ZSCAN10 locus itself.

Chromosomal abnormalities: None reported — OFNS is caused by small intragenic PTVs, not by copy-number/structural chromosomal rearrangements. (Note: a phenotypically distinct entity, "Chromosome 16p13.3 duplication syndrome," exists in the same cytogenetic region but is a separate, contiguous-gene-duplication condition, not OFNS — flagged here to avoid Named Entity Confusion.)

5. Environmental Information

No environmental, lifestyle, or infectious contributing factors have been identified or are biologically plausible for this monogenic transcription-factor disorder. Not applicable.

6. Mechanism / Pathophysiology

Causal chain (upstream → downstream): 1. Molecular trigger: Bi-allelic PTVs in ZSCAN10 exon 6 → truncated protein lacking most C2H2 zinc-finger DNA-binding motifs. 2. Subcellular consequence: Loss of nuclear localization (mutant protein mislocalizes to cytoplasm) → loss of transcription-factor access to target gene promoters. 3. Molecular/transcriptional consequence: Loss of ZSCAN10 binding at target promoters, including POU5F1 (OCT4) → dysregulation of pluripotency/developmental transcriptional network (Pou5f1, Sall4, Mtf2, Hoxb13, Meis2) and of ATP-dependent chromatin-remodeling pathway genes. 4. Cellular/developmental consequence: Disrupted transcriptional regulation during embryonic stem cell maintenance/early differentiation programs affecting cranial neural crest- and otic placode-derived structures. 5. Tissue/organ consequence: Aberrant morphogenesis of first/second pharyngeal-arch-derived facial structures (facial asymmetry) and otic-vesicle-derived structures (outer ear, semicircular canals, cochlea) → structural malformation and secondary sensorineural hearing loss; disrupted CNS developmental gene networks → global developmental delay/intellectual disability. 6. Organism-level manifestation: The OFNS clinical triad (developmental delay + facial asymmetry + oto-facial malformation/hearing loss), plus variably penetrant additional features (micropenis, cardiac defect, cleft palate, behavioral abnormalities).

Molecular pathway: ZSCAN10 acts as a C2H2 zinc-finger/SCAN-domain transcription factor operating within (and adjacent to) the core pluripotency transcriptional network alongside OCT4 (POU5F1), SOX2, and NANOG in embryonic stem cells, with genome-wide ChIP evidence of >3,000 binding sites, 183 of which overlap the OCT4/SOX2/NANOG trio — consistent with both direct and indirect roles in orchestrating developmental gene-regulatory programs. Suggested GO terms: GO:0003700 (DNA-binding transcription factor activity), GO:0000981 (RNA polymerase II-specific DNA-binding transcription factor activity), GO:0019827/GO:1902459 (stem cell population maintenance / positive regulation thereof), GO:0006338 (chromatin remodeling; specifically ATP-dependent chromatin remodeling per the KEGG-flagged pathway).

Cellular processes: Disrupted stem-cell transcriptional maintenance and differentiation-associated chromatin remodeling during embryogenesis (not apoptosis, autophagy, or classic inflammatory mechanisms). Suggested CL term: CL:0002322 (embryonic stem cell) as the primary cellular substrate studied.

Protein dysfunction: Loss-of-function via truncation — loss of most zinc-finger DNA-binding domains plus aberrant subcellular localization (nuclear-to-cytoplasmic mislocalization of the truncated protein), rather than a gain-of-function or dominant-negative mechanism. Note a contextual duality: separate oncology literature (PMID:31933877) reports ZSCAN10 overexpression promoting glioma proliferation via OCT4 upregulation and Wnt/β-catenin activation — the inverse (gain-of-function/oncogenic) context, underscoring that ZSCAN10's normal role is dosage-sensitive and context-dependent. This is mechanistically distinct from OFNS and should not be conflated with the germline loss-of-function disease mechanism.

Immune system involvement: None reported/implicated.

Tissue damage mechanisms: Not applicable — this is a developmental morphogenesis defect (malformation) rather than a degenerative or injury-based tissue-damage mechanism.

Molecular profiling performed to date: - Transcriptomics: RNA-seq of Zscan10⁻/⁻ vs wild-type mESCs (1,310 DEGs) — PMID:38386308. - Genomic structural features: 3D geometric morphometric analysis of mouse embryonic craniofacial and inner-ear structures at E14.5 (26 surface landmarks + 22 inner-ear landmarks; Procrustes superimposition and fluctuating-asymmetry analysis). - ChIP-qPCR: confirming direct ZSCAN10–Pou5f1 promoter binding, lost in the truncated mutant. - No proteomics, metabolomics, lipidomics, single-cell, or spatial transcriptomic data have yet been published for this disorder.

7. Anatomical Structures Affected

Organ level: - Primary: Face (asymmetry, dysmorphic features), outer ear (microtia, low-set/posteriorly rotated position, absent superior crus), inner ear (semicircular canal dysplasia, cochlear shortening in the mouse model), brain/CNS (developmental delay/intellectual disability — no structural cerebral anomalies noted on MRI beyond the otic findings). - Secondary: Cardiovascular (mild left ventricular enlargement, 1/7), palate (cleft palate, 1/7), genitourinary (micropenis, cryptorchidism), eyes (visual impairment in 3/7, mechanism unspecified). - Body systems involved: nervous system, craniofacial/musculoskeletal (ear/face), auditory/vestibular system, cardiovascular system, genitourinary system.

Suggested UBERON terms: UBERON:0000980 (face), UBERON:0001756 (external ear / outer ear), UBERON:0001846 (inner ear... note: verify exact ID via OAK — likely UBERON:0001846 for inner ear or UBERON:0002105 depending on version), UBERON:0001850 (semicircular canal), UBERON:0001844 (cochlea), UBERON:0001987 (palate).

Tissue and cell level: Craniofacial/pharyngeal-arch-derived neural-crest mesenchyme and otic-vesicle/otic-placode-derived epithelium are the developmental substrates implicated (inferred from the malformation pattern and mouse embryo findings), alongside the broadly studied embryonic stem cell (CL:0002322) as the in vitro model system for molecular mechanism.

Subcellular level: Nucleus (site of normal ZSCAN10 transcription-factor activity; GO Cellular Component GO:0005634) versus cytoplasm (site of aberrant mutant-protein mislocalization; GO:0005737).

Localization/laterality: Facial asymmetry and ear malformations are frequently bilateral but asymmetric in severity, sometimes strictly unilateral (2/7 unilateral outer-ear malformation; hearing loss ranging from unilateral to bilateral) — a distinctive "fluctuating asymmetry" pattern rather than fixed bilateral symmetry, also reproduced and quantified in the Zscan10⁻/⁻ mouse model.

8. Temporal Development

Onset: Congenital — facial asymmetry and ear malformations are present from birth; developmental delay is recognized in infancy/early childhood. No adult-onset or late-onset presentation reported. Onset pattern: Insidious/congenital structural and developmental (not acute). Progression: The malformative features (ear/face) are static/non-progressive congenital anomalies; the neurodevelopmental phenotype (developmental delay, cognitive impairment) is a stable, non-degenerative deficit typical of a transcriptional-regulator neurodevelopmental disorder — no reported evidence of regression or progressive decline. Disease course pattern: Stable, chronic, lifelong (congenital malformation + static neurodevelopmental impairment); not episodic or relapsing-remitting. Disease stages: Not formally staged — disease is not classified by stage/grade systems (unlike cancers). Remission patterns: Not applicable (congenital structural/developmental disorder, not a remitting condition). Critical periods: Embryonic craniofacial and otic morphogenesis (first-second pharyngeal arch and otic vesicle development, roughly corresponding to human 4th–8th gestational weeks by analogy to the mouse E14.5 model timepoint) represents the developmental window of vulnerability, based on the mouse embryo phenotyping timepoint.

9. Inheritance and Population

Epidemiology: Extremely rare — only 7 affected individuals from 5 families reported worldwide as of the founding 2024 publication; no formal prevalence or incidence estimate exists (likely well below 1/1,000,000; the disorder would fall in an ultra-rare/"cases in literature" prevalence class per Orphanet-style banding, with prevalence_class: NOT_YET_DOCUMENTED or CASES_IN_LITERATURE being the most defensible dismech curation choice).

Inheritance pattern: Autosomal recessive (AR) — confirmed by bi-allelic (homozygous or compound heterozygous) variant findings and full co-segregation with phenotype in family members tested.

Penetrance: Appears complete for the core phenotype (developmental delay + ear malformation) among the 7 reported bi-allelic carriers, though expressivity is markedly variable (see below); formal penetrance estimates are not available given the small cohort.

Expressivity: Highly variable — cognitive impairment ranges mild to profound; facial asymmetry present in 5/7; hearing loss severity ranges unilateral-mild to bilateral-profound; additional features (cardiac defect, cleft palate, micropenis, behavioral abnormalities) are present in only a subset, indicating variable expressivity even among carriers of the identical recurrent allele (c.1456C>T).

Genetic anticipation: Not applicable/not reported (not a repeat-expansion disorder).

Germline mosaicism: Not reported.

Founder effects: Strong evidence for a South/West Asian founder allele at c.1456C>T (p.Gln486*), shared among Turkish, Iranian, Indian, and Pakistani families, supported by shared runs of homozygosity (2.5–8.1 Mb) in families F2 and F5 and elevated allele frequency specifically in the gnomAD South Asian subpopulation.

Consanguinity role: Likely significant, consistent with the populations sampled and the autosomal recessive homozygous presentations in most families.

Carrier frequency: Estimated from gnomAD: ~7×10⁻⁴ heterozygote frequency for c.1456C>T specifically in the South Asian gnomAD subpopulation (i.e., roughly 1 in ~1,400 in that specific reference subpopulation); overall population carrier frequency across all ZSCAN10 PTV alleles is not separately reported.

Population demographics: All reported families are of Turkish (1), Iranian (4), Indian (1), and Pakistani (1) origin — a South/West/Central Asian geographic clustering, likely reflecting both the founder allele and ascertainment bias (genetic referral centers with expertise in consanguineous-population Mendelian disease gene discovery) rather than necessarily reflecting the disorder's true global geographic distribution. Sex ratio: 3 females : 4 males reported — roughly equal, consistent with autosomal (non-X-linked) inheritance. Age distribution: Patients examined ranged from 1 year 8 months to 15 years at time of report — a pediatric/adolescent cohort; no adult patients yet described (disease is presumably lifelong but long-term adult natural history is unknown).

10. Diagnostics

Laboratory tests / biomarkers: No specific diagnostic biochemical or serum biomarker exists; diagnosis is genetic/imaging-based, not biochemical.

Imaging studies: - MRI of the temporal bone/inner ear: demonstrated bilateral semicircular canal dysplasia in both patients with available imaging (2/2), plus subtle osseous asymmetry of the skull and midface; no other cerebral structural anomalies identified. - 3D facial/craniofacial imaging: used in the mouse model (geometric morphometrics) and, in patients, computational facial-analysis tools (GestaltMatcher) were applied to frontal facial photographs to validate the facial-asymmetry phenotype, achieving 82% (41/50) correct classification for asymmetry detection, with all 6 affected individuals' frontal images correctly classified.

Functional tests / electrophysiology: - Audiology (audiometry): sensorineural hearing loss documented in 4/5 tested individuals, ranging from unilateral deafness to profound bilateral loss. No vestibular symptoms (vertigo/imbalance) reported despite structural inner-ear pathology.

Biopsy/pathology: Not applicable/not performed — this is a structural developmental disorder, not evaluated by tissue biopsy.

Genetic testing: - Recommended approach: Given the phenotype's rarity and gene-discovery status (2024), diagnosis currently relies on exome or genome sequencing (the modality by which all 7 reported cases were identified) rather than a targeted panel, as ZSCAN10 is unlikely to yet be included on most commercial hearing-loss or intellectual-disability gene panels. - WES/WGS utility: High — this is precisely how the causal gene was discovered (trio/family exome sequencing with homozygosity mapping in consanguineous families). - Single-gene testing: Feasible for confirmed familial variants once identified in a proband (e.g., targeted Sanger confirmation of the recurrent c.1456C>T allele in South Asian families). - Chromosomal microarray/karyotype/FISH: Not the diagnostic modality of choice (disease is due to small intragenic PTVs, not copy-number/structural chromosomal changes), though may be used to exclude a differential such as 16p13.3 duplication/deletion syndrome. - Mitochondrial DNA / repeat-expansion testing: Not applicable.

Omics-based diagnostics: Not yet in routine/research diagnostic use for this disorder; RNA-seq and ChIP-qPCR were used as research validation tools (mESC model), not as clinical diagnostic assays.

Clinical criteria: No formal consensus diagnostic criteria (DSM/ICD/society guidelines) yet exist, given the 2024 initial description; diagnosis currently rests on the combination of (a) bi-allelic ZSCAN10 PTV and (b) the characteristic phenotypic triad (developmental delay + facial asymmetry + oto-facial malformation/hearing loss).

Differential diagnosis: Should include other syndromic causes of combined craniofacial-asymmetry + ear-malformation + developmental delay, e.g., oculo-auriculo-vertebral spectrum (Goldenhar/hemifacial microsomia), CHARGE syndrome, branchio-oto-renal spectrum disorders, and other zinc-finger transcription-factor neurodevelopmental disorders — though a detailed differential-diagnosis discussion was not part of the identified literature and would benefit from independent verification.

Screening: No newborn or population screening program exists (disease too rare/recently described); no cascade or carrier screening program established, though targeted carrier testing for the recurrent c.1456C>T allele could be considered in high-risk South/West Asian consanguineous families given the founder-effect data.

11. Outcome/Prognosis

Survival/mortality: No mortality data reported among the 7 described patients; no evidence the condition is life-limiting based on available data, though the cohort is small and long-term follow-up is not yet published.

Morbidity/function: Long-term functional outcomes are not systematically reported; morbidity is driven by the combination of intellectual disability (mild-to-profound), hearing impairment (unilateral to profound bilateral sensorineural loss), and — in a subset — cardiac, palatal, or genitourinary anomalies requiring their own management.

Quality of life measures: None formally reported/available.

Complications: Feeding/speech difficulties secondary to cleft palate (1/7); potential cardiac monitoring needs for the individual with LV enlargement; genitourinary complications (undescended testis) requiring surgical correction; behavioral complications (aggression, autistic features) impacting social/adaptive function.

Recovery potential: Not a degenerative disease — the structural anomalies are fixed/congenital and the neurodevelopmental impairment is expected to be a static (not progressive) encephalopathy-type course, so "recovery" in the sense of reversal is not expected, but developmental gains with early intervention are plausible by analogy to other neurodevelopmental disorders (not disease-specifically demonstrated yet).

Prognostic factors: Not yet established given the small cohort; qualitatively, the marked variable expressivity (mild-to-profound cognitive range) suggests that individual outcome cannot currently be predicted from genotype alone (multiple individuals shared the identical c.1456C>T allele yet had differing symptom severity).

Prognostic biomarkers: None identified.

12. Treatment

No disease-specific/targeted therapy exists for OFNS (a very recently described monogenic disorder); management is supportive and multidisciplinary, addressing each component of the phenotype by extrapolation from standard care for its constituent features. No treatment outcome data (response rates, disease-specific trial results) exist for OFNS itself.

Pharmacotherapy: No specific pharmacological treatment targets ZSCAN10 or its pathway; symptomatic pharmacotherapy (e.g., for behavioral features such as aggression) would follow standard neurodevelopmental-disorder practice, not disease-specific evidence. Suggested NCIT term: NCIT:C15986 (Pharmacotherapy), used only for symptomatic/behavioral management, not disease-modifying treatment.

Advanced therapeutics: No gene therapy, cell therapy, RNA-based therapy, targeted therapy, or immunotherapy has been developed or trialed for OFNS. Given the loss-of-function truncating mechanism, gene-replacement/augmentation strategies are theoretically conceivable but entirely unstudied/speculative — should not be curated as an actual treatment.

Surgical/interventional: - Cleft palate repair — standard surgical correction for the 1/7 patient with cleft palate. NCIT: NCIT:C15329 (Surgical Procedure). - Orchidopexy for cryptorchidism/maldescended testis. NCIT: NCIT:C15329 (Surgical Procedure) or more specific urologic term if available. - Cochlear implantation may be indicated for patients with profound bilateral sensorineural hearing loss (standard-of-care extrapolation, not disease-specifically reported). - Reconstructive otoplasty may be considered for microtia/outer-ear malformation as in other syndromic microtia conditions (extrapolated, not disease-specifically reported).

Supportive/rehabilitative care: - Hearing aids for less-than-profound sensorineural hearing loss (no dedicated NCIT term exists for "hearing aid usage" per the dismech NCIT remapping notes). - Speech-language therapy — NCIT:C159273 (Speech Therapy) — for delayed/absent speech. - Physical/occupational therapy — NCIT:C15302 (Physical Therapy) / NCIT:C121351 (Occupational Therapy) — for motor delay. - Developmental/early intervention programs and special-education support for global developmental delay/intellectual disability. - Behavioral therapy for autistic features, aggression, and stereotypy. - Genetic counseling — NCIT:C15240 (Genetic Counseling) — for recurrence-risk counseling in autosomal recessive inheritance, particularly relevant given the consanguinity/founder-allele context. - Cardiology follow-up for the subset with cardiac defects.

Experimental treatments: None identified in ClinicalTrials.gov or the literature search for ZSCAN10/OFNS specifically as of this report.

Treatment strategy: No published treatment algorithm exists; management is individualized and multidisciplinary (genetics, otolaryngology/audiology, cardiology, urology, developmental pediatrics, speech/OT/PT), following general principles for syndromic neurodevelopmental disorders rather than an OFNS-specific protocol.

13. Prevention

Primary prevention: Not applicable in the classic sense (this is a Mendelian genetic disease, not preventable by risk-factor modification); the only "primary prevention" lever is reproductive/genetic counseling in at-risk (consanguineous, or carriers of the South Asian founder allele) families, including discussion of preimplantation genetic diagnosis (PGD) or prenatal testing once a familial variant is known.

Secondary prevention: Early diagnosis via genetic testing in families with a known proband, followed by early audiological/developmental screening and intervention to mitigate downstream functional impact of hearing loss and developmental delay.

Tertiary prevention: Multidisciplinary management (above) to prevent/minimize complications (e.g., surgical correction of cleft palate to prevent feeding/speech complications; hearing amplification/cochlear implantation to mitigate the impact of hearing loss on language development).

Immunization: Not applicable — no infectious component.

Screening/genetic counseling: Carrier screening for the recurrent c.1456C>T allele could be considered in high-risk South/West Asian consanguineous populations given the demonstrated founder effect, though no formal population carrier-screening program has been established. Prenatal testing/PGD is feasible once a familial pathogenic variant is identified.

Public health/environmental interventions: Not applicable (no environmental risk factor identified).

Prophylaxis: Not applicable.

14. Other Species / Natural Disease

No naturally occurring ZSCAN10-deficient disease has been reported in companion animals or wildlife (no OMIA entry identified in this search). ZSCAN10 orthologs exist across mammals (e.g., mouse Zscan10, NCBI Gene; rat Zscan10, RGD:1310745; dog ZSCAN10, NCBI Gene 490045), but disease association has only been established via engineered knockout models (see Model Organisms below), not spontaneous natural disease in non-human species.

15. Model Organisms

Primary model: Mouse (Mus musculus), Zscan10 knockout — the core functional-validation model in the founding paper (PMID:38386308). - Model type: Genetically engineered knockout-first allele, Zscan10^tm2a(EUCOMM)Wtsi, generated via a LacZ-cassette insertion upstream of exon 6 (International Mouse Phenotyping Consortium / EUCOMM resource lineage). This model reportedly showed higher embryonic lethality than previously published Zscan10 knockout models. - Phenotype recapitulation (E14.5 embryos): - Significant fluctuating facial asymmetry compared to wild-type littermates (quantified via 3D geometric morphometrics, 26 surface landmarks, Procrustes superimposition). - Smaller eye size and ear opening on 3D imaging. - Misalignment of the semicircular canals and shortening of the cochlea (22-landmark inner-ear 3D morphometric analysis) — directly recapitulating the human inner-ear dysplasia phenotype. - Skull-shape differences on principal component analysis of symmetric shape variation. - Model limitations: The knockout model is embryonic-lethal at higher rates than prior alleles, limiting study to embryonic timepoints (E14.5) rather than postnatal/adult phenotyping (e.g., postnatal hearing function, adult behavior, or long-term developmental outcomes cannot be directly assessed in a highly embryonic-lethal line). No mouse behavioral/cognitive phenotyping (correlating to the human developmental delay/intellectual disability phenotype) was reported in the available search results. - Research applications: Craniofacial and inner-ear developmental morphogenesis; validating the causal role of Zscan10 loss in the oto-facial malformation phenotype independent of possible confounding in human genetic background. - Resource: IMPC/EUCOMM allele resources (MGI database).

Secondary model: Mouse embryonic stem cells (mESCs), Zscan10⁻/⁻ — an in vitro cellular model used for transcriptomic and mechanistic (ChIP-qPCR, subcellular localization) studies described in Section 6/4 above (PMID:38386308). This model recapitulates the molecular-level pathomechanism (transcriptional dysregulation of pluripotency/developmental genes, loss of POU5F1 promoter binding) but does not model the whole-organism phenotype.

Related, disease-adjacent (not disease-causing) model literature on Zscan10 biology (informative for mechanism, not for OFNS phenotype recapitulation per se): - Cai et al., "Pleiotropic Functions for Transcription Factor Zscan10" (PLoS ONE; PMID available via PMC4128777) — establishes Zscan10's genome-wide binding-site profile and role alongside Oct4/Sox2/Nanog in ESC gene regulation. - Nagelreiter et al., "Zscan10 is dispensable for maintenance of pluripotency in mouse embryonic stem cells" (PMID: 26592664) — an important nuance/caveat: this earlier study found Zscan10 was not required for baseline ESC self-renewal/pluripotency maintenance under standard culture conditions, which contextualizes the newer OFNS paper's findings as revealing a developmental (in vivo, organismal) rather than a strict cell-autonomous pluripotency-maintenance requirement — a good candidate for a HUMAN_MODEL_MISMATCH/nuance discussion node if curated into dismech, since apparent mESC dispensability contrasts with clear organismal necessity for normal craniofacial/otic development. - Ma et al., "ZSCAN10 promotes cell proliferation, upregulates OCT4 expression, and activates Wnt/β-catenin signaling in glioma" (PMID: 31933877) — describes an oncogenic, gain-of-function-type role for ZSCAN10 in glioma, mechanistically distinct from (and not to be conflated with) the germline loss-of-function OFNS mechanism; useful context for the gene's normal dosage-sensitive biology but not itself an OFNS model.

Other species (non-model, orthology only): No functional disease modeling reported in zebrafish, Drosophila, C. elegans, or yeast for ZSCAN10/OFNS in the available search results.

Summary Evidence Table (Primary Citations)

Claim PMID/Source Evidence type
OFNS gene discovery, clinical cohort (n=7/5 families), variant spectrum, GestaltMatcher facial analysis PMID:38386308 (Laugwitz et al. 2024, Brain 147:2471–2482) HUMAN_CLINICAL
Zscan10⁻/⁻ mouse embryo craniofacial/inner-ear morphometrics PMID:38386308 MODEL_ORGANISM
Zscan10⁻/⁻ mESC RNA-seq, ChIP-qPCR subcellular localization/DNA-binding studies PMID:38386308 IN_VITRO
ZSCAN10 genome-wide binding sites, role with Oct4/Sox2/Nanog PMC4128777 (Cai et al., PLoS ONE) IN_VITRO
Zscan10 dispensability for baseline ESC pluripotency maintenance PMID:26592664 IN_VITRO
ZSCAN10 oncogenic role in glioma (gain-of-function context) PMID:31933877 IN_VITRO / MODEL_ORGANISM (mixed — verify per-claim before citing)

Curatorial caveats for dismech entry construction: 1. All PMIDs above must be independently fetched (just fetch-reference PMID:XXXX) and snippets validated against cached abstracts before use — this report's quotes were extracted via web fetch of the PMC full text, not yet run through the dismech reference-validation pipeline. 2. Orphanet and ICD identifiers could not be confirmed as existing yet for this very recently named condition (2024) — do not fabricate an Orphanet/ICD code; leave absent or explicitly note "not yet assigned" pending independent verification at curation time. 3. HPO term IDs suggested above (especially for semicircular canal dysplasia, downslanted palpebral fissures, epicanthus) should be verified with OAK (uv run runoak -i sqlite:obo:hp info <ID> -O obo) before committing to the KB, per standard dismech term-validation practice. 4. Given the extreme rarity/recency (single founding publication), this entry is a strong candidate for conservative curation with heavy reliance on notes: for claims lacking a directly quotable snippet, and appropriate use of MECHANISTIC_HYPOTHESIS/HUMAN_MODEL_MISMATCH framing for extrapolated (not disease-specifically demonstrated) treatment and prognosis content.

Sources: - Otofacial neurodevelopmental syndrome (Concept Id: C5935642) - MedGen - NCBI - Otofacial Neurodevelopmental Syndrome - MalaCards - Entry - #620910 - OTOFACIAL NEURODEVELOPMENTAL SYNDROME; OFNS - OMIM - Clinical Synopsis - #620910 - OMIM - otofacial neurodevelopmental syndrome - Monarch Initiative - ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations - Brain (Oxford Academic) - ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations - PMC - Entry - *618365 - ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10 - OMIM - ZSCAN10 Gene - GeneCards - Pleiotropic Functions for Transcription Factor Zscan10 - PLOS ONE / PMC - Zscan10 is dispensable for maintenance of pluripotency in mouse embryonic stem cells - PubMed - ZSCAN10 promotes cell proliferation, upregulates OCT4 expression, and activates Wnt/β-catenin signaling in glioma - PMC - ZSCAN10 zinc finger and SCAN domain containing 10 [Homo sapiens] - Gene - NCBI - Gene: ZSCAN10 (ENSG00000130182) - Ensembl

Falcon ▸
Otofacial Neurodevelopmental Syndrome: Disease-Characteristics Report
Edison Scientific Literature 5 citations 2026-07-31T18:15:05.206435

Otofacial Neurodevelopmental Syndrome: Disease-Characteristics Report

Executive summary and evidence limits

Otofacial neurodevelopmental syndrome is an ultra-rare, newly delineated autosomal-recessive developmental disorder caused by biallelic loss-of-function variants in ZSCAN10. The disease-defining publication reported only seven affected individuals, so essentially all frequency estimates remain provisional. Its most reproducible features are global developmental delay, facial asymmetry, external-ear malformations, semicircular-canal dysplasia, and sensorineural hearing loss (SNHL), confirmed in 4/5 individuals tested. The current MONDO identifier is MONDO:0975705. Open Targets lists ZSCAN10 as the sole associated target and links the association to PMID 38386308. (OpenTargets Search: Otofacial neurodevelopmental syndrome, owrang2025neurogeneticdisorderswith pages 13-14)

The foundational primary report is Laugwitz L, Cheng F, Collins SC, et al., “ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations,” Brain. 2024;147(7):2471–2482, PMID: 38386308; PubMed: https://pubmed.ncbi.nlm.nih.gov/38386308/. A subsequent authoritative review is Owrang D, Vona B, “Neurogenetic Disorders with Hearing Loss: Mechanisms, Classifications, and Emerging Insights,” published November 2025, DOI: https://doi.org/10.1007/s11910-025-01466-y. (owrang2025neurogeneticdisorderswith pages 13-14, owrang2025neurogeneticdisorderswith pages 18-19)

Domain Established finding Quantitative evidence Suggested ontology/identifier Evidence status/limitations
Disease entity Otofacial neurodevelopmental syndrome is a recently defined Mendelian disorder linked to ZSCAN10 deficiency 1 disease-target association in Open Targets (score 0.607) MONDO:0975705 Disease appears newly described; cross-resource coverage is still sparse (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Causal gene The only currently associated gene identified in retrieved disease-level resources is ZSCAN10 1 associated target; 5-7 evidence records depending on source view ZSCAN10; ENSG00000130182 Evidence in retrieved materials converges on a single gene, but detailed variant list was not recoverable from available contexts (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Foundational report Primary disease-defining report is Laugwitz et al., Brain (2024) 7 affected individuals reported PMID:38386308; Brain 2024; DOI/publication details cited in review Full primary-text patient table/variant appendix not available in retrieved contexts (owrang2025neurogeneticdisorderswith pages 18-19)
Inheritance Reported as biallelic loss-of-function disorder with autosomal recessive inheritance 7 affected individuals from the foundational cohort Autosomal recessive; germline inherited disorder Open Targets also notes one entry as “biallelic, autosomal or pseudoautosomal”; autosomal recessive is the clearer formulation from review-based clinical summary (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Variant class Pathogenic alleles are described as loss-of-function, including frameshift and stop-gained/nonsense classes High-confidence variant evidence scores ~0.90-0.92 in Open Targets/EVA-backed entries Loss-of-function variant class Exact HGVS nomenclature and allele frequencies were not available in retrieved contexts (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Core neurodevelopmental phenotype Global developmental delay is a consistent clinical feature Described as present consistently across the 7 affected individuals Suggested HPO term: global developmental delay No fine-grained severity percentages or developmental testing metrics available from retrieved contexts (owrang2025neurogeneticdisorderswith pages 13-14)
Craniofacial phenotype Facial asymmetry is part of the characteristic phenotype Reported consistently in the 7 affected individuals Suggested HPO term: facial asymmetry Frequency reported qualitatively as consistent; no standardized dysmorphology breakdown available here (owrang2025neurogeneticdisorderswith pages 13-14)
External ear phenotype Outer-ear malformations are characteristic Reported consistently in the 7 affected individuals Suggested HPO term: external ear malformation / abnormality of the external ear Specific malformation subtypes were not available in retrieved contexts (owrang2025neurogeneticdisorderswith pages 13-14)
Inner ear anatomy Semicircular-canal dysplasia documented on cerebral MRI/inner-ear imaging Present in imaged affected individuals per review summary; exact denominator not stated Suggested HPO term: semicircular canal dysplasia; UBERON: semicircular canal Anatomical description is available, but full radiology details and laterality were not recoverable (owrang2025neurogeneticdisorderswith pages 13-14)
Hearing phenotype Sensorineural hearing loss (SNHL) is a major associated feature 4/5 tested individuals had confirmed SNHL Suggested HPO term: sensorineural hearing impairment Denominator indicates incomplete testing; true frequency among all affected individuals remains uncertain (owrang2025neurogeneticdisorderswith pages 13-14)
Anatomical systems affected Disorder involves nervous system, craniofacial structures, outer ear, and inner ear/vestibular apparatus At least 4 organ-system domains implicated by reported phenotype set Suggested UBERON labels: brain, external ear, inner ear, semicircular canal Direct cellular pathology for each tissue has not yet been defined in retrieved sources (owrang2025neurogeneticdisorderswith pages 13-14)
Molecular function ZSCAN10 is a zinc finger and SCAN domain-containing transcription factor implicated in control of embryonic stem-cell pluripotency Qualitative functional role, no disease-specific effect size reported ZSCAN10; transcription factor; pluripotency-related regulator Disease mechanism beyond this high-level role remains incompletely resolved in available contexts (owrang2025neurogeneticdisorderswith pages 13-14)
Mechanism / pathophysiology Current understanding supports an upstream defect in transcriptional regulation during development, plausibly affecting neurodevelopment and otic/craniofacial morphogenesis Evidence is descriptive rather than pathway-quantified Suggested GO labels: regulation of transcription, stem cell maintenance, developmental process Review explicitly notes that precise downstream targets remain unknown; no validated disease pathway map retrieved (owrang2025neurogeneticdisorderswith pages 13-14)
Age at onset / course Findings are most compatible with congenital or early-childhood onset neurodevelopmental disorder No exact onset ages available in retrieved contexts Suggested onset label: congenital/infancy/childhood onset Formal natural-history data, progression rate, and lifespan data unavailable (owrang2025neurogeneticdisorderswith pages 13-14, owrang2025neurogeneticdisorderswith pages 18-19)
Epidemiology Prevalence and incidence are unknown Only 7 affected individuals identified in available foundational report Ultra-rare Mendelian disorder No population-based studies, registries, or prevalence estimates identified in retrieved contexts (owrang2025neurogeneticdisorderswith pages 18-19, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Population genetics No founder effect, carrier frequency, penetrance estimate, or ancestry-specific enrichment established from available contexts Not reported Not established These fields remain evidence gaps pending larger cohorts and database curation (owrang2025neurogeneticdisorderswith pages 18-19, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Diagnostics Most evidence-supported diagnosis is genomic testing identifying biallelic ZSCAN10 loss-of-function variants, with phenotypic support from hearing assessment and imaging of inner-ear anomalies 7 molecularly defined individuals; hearing loss confirmed in 4/5 tested Molecular diagnosis; ZSCAN10 sequencing; consider exome/genome in neurodevelopmental + hearing-loss workup No formal disease-specific diagnostic criteria or validated biomarker studies retrieved (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Clinical implementation Broader expert opinion in neurogenetic hearing loss recommends considering neurogenetic diagnosis when hearing loss co-occurs with developmental delay, hypotonia, or regression Qualitative recommendation Neurogenetic hearing-loss diagnostic framework This is expert contextual guidance, not disease-specific management consensus for ZSCAN10 syndrome (owrang2025neurogeneticdisorderswith pages 13-14)
Treatment No disease-specific therapy established in retrieved sources 0 disease-specific treatments identified Supportive care only (conceptual) No pharmacotherapy, gene therapy, trial, or interventional outcome data retrieved (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Prognosis Unknown from current retrieved evidence No survival or long-term outcome series identified Not established Natural history, mortality, functional outcomes, and quality-of-life metrics are not yet defined (owrang2025neurogeneticdisorderswith pages 18-19, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Environmental / lifestyle factors No disease-specific environmental, lifestyle, infectious, or gene-environment risk factors established 0 identified Not applicable/unknown Consistent with a rare Mendelian disorder; absence of evidence should not be overinterpreted as evidence of absence (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Protective factors No genetic or environmental protective factors identified 0 identified Not established No modifier/protective data available in retrieved contexts (OpenTargets Search: Otofacial neurodevelopmental syndrome)
Omics / epigenetics No disease-specific transcriptomic, proteomic, metabolomic, lipidomic, or epigenomic datasets were retrieved 0 disease-specific omics studies identified in available contexts Not established Mechanistic inference is based mainly on known gene function, not disease-specific multi-omics evidence (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)
Model organisms / natural disease No disease-specific animal model or naturally occurring non-human disease evidence was retrieved 0 disease-specific models identified Not established Although ZSCAN10 has broader stem-cell biology literature, no syndrome-specific model evidence was available in retrieved contexts (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)

Table: This table provides an evidence-bound summary of what is currently established versus unknown for otofacial neurodevelopmental syndrome, centered on the 2024 ZSCAN10 cohort report and supporting disease-resource evidence. It is useful for rapid knowledge-base population while clearly separating confirmed findings from gaps.

1. Disease information

Definition

This is a congenital/early-childhood syndromic neurodevelopmental disorder combining impaired neurodevelopment with characteristic craniofacial, external-ear, inner-ear, and auditory abnormalities. “ZSCAN10 deficiency” is the mechanistically preferable name because the demonstrated cause is biallelic ZSCAN10 loss of function. (owrang2025neurogeneticdisorderswith pages 13-14)

Identifiers and names

  • MONDO: MONDO:0975705.
  • Causal gene: ZSCAN10, zinc finger and SCAN domain containing 10.
  • Ensembl gene: ENSG00000130182.
  • Primary-literature PMID: 38386308.
  • Useful synonyms: ZSCAN10-related otofacial neurodevelopmental syndrome; ZSCAN10 deficiency; neurodevelopmental disorder with characteristic oto-facial malformations.
  • OMIM, Orphanet, MeSH, ICD-10, and ICD-11: no disease-specific identifiers were established in the retrieved evidence. Broad codes such as developmental disorder, congenital ear malformation, or hearing loss would be nonspecific and should not be represented as exact disease mappings. (OpenTargets Search: Otofacial neurodevelopmental syndrome, owrang2025neurogeneticdisorderswith pages 18-19)

The evidence is aggregated disease-level evidence derived from individually phenotyped patients, not EHR-derived population surveillance. The primary cohort comprised seven molecularly diagnosed individuals; Open Targets subsequently aggregated genetic evidence from EVA, UniProt literature, and Genomics England. (OpenTargets Search: Otofacial neurodevelopmental syndrome)

2. Etiology

Causal and genetic factors

The established cause is germline biallelic loss of function in ZSCAN10, consistent with autosomal-recessive inheritance. Retrieved disease-resource evidence includes frameshift and stop-gained alleles, with Open Targets/EVA confidence scores of approximately 0.90–0.92. Exact HGVS descriptions were not recoverable from the available primary-text extract and should therefore be imported directly from PMID 38386308, ClinVar, or EVA rather than inferred. (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)

Family history, parental consanguinity, and carrier status may increase recurrence risk in the usual autosomal-recessive manner, but no founder allele, carrier frequency, modifier gene, susceptibility locus, or ancestry-specific enrichment has been established.

Environmental, infectious, and lifestyle factors

No toxins, medications, radiation, infection, maternal exposure, diet, smoking, alcohol, occupation, or other environmental cause has been linked specifically to this syndrome. No gene–environment interaction has been demonstrated. This is a monogenic developmental disorder; environmental contributors should not be asserted without new evidence.

Protective factors

No protective ZSCAN10 alleles, modifier variants, dietary factors, lifestyle exposures, or pharmacologic prophylaxis are known. Population loss-of-function constraint and allele frequencies require direct gnomAD review at variant level.

3. Phenotypes

The small denominator makes “consistent” more appropriate than a population-level percentage except where a tested denominator was reported.

Phenotype Type and characteristics Observed frequency Suggested HPO term
Global developmental delay Neurodevelopmental sign; early-childhood recognition; severity and developmental domains not fully quantified Described consistently among 7 cases Global developmental delay
Facial asymmetry Congenital physical manifestation/dysmorphology; likely stable Described consistently among 7 cases Facial asymmetry
External-ear malformation Congenital structural sign; subtype and laterality unavailable Described consistently among 7 cases Abnormality of the external ear / external-ear malformation
Semicircular-canal dysplasia Inner-ear imaging abnormality; congenital structural defect Denominator not specified in retrieved extract Abnormal semicircular canal morphology / semicircular-canal dysplasia
Sensorineural hearing loss Auditory functional impairment; onset and severity incompletely reported 4/5 tested (80%) Sensorineural hearing impairment

These findings are directly summarized in the review as: “Biallelic ZSCAN10 loss-of-function variants were identified in seven affected individuals who consistently reported global developmental delay, facial asymmetry and malformations of the outer ear.” It further states that imaging showed semicircular-canal dysplasia and that “4/5 individuals were confirmed with SNHL.” (owrang2025neurogeneticdisorderswith pages 13-14)

No robust data are available for seizures, behavior, cognition level, speech, motor milestones, hypotonia, vestibular symptoms, growth, ophthalmology, laboratory abnormalities, or other organ involvement. Their absence from this report must not be interpreted as clinical absence.

Quality-of-life implications

No EQ-5D, SF-36, PROMIS, or syndrome-specific quality-of-life study exists in the retrieved evidence. Nevertheless, developmental delay can impair education and independent daily functioning, while SNHL can compound speech-language and social-communication disability. That functional interpretation is clinically reasonable but has not been quantified in this syndrome.

4. Genetic and molecular information

ZSCAN10 encodes a zinc-finger and SCAN-domain transcription factor. The current evidence supports biallelic germline truncating variants—frameshift and nonsense/stop-gained—as the pathogenic class. The expected consequence is loss of functional protein, rather than gain of function or dominant-negative action. Somatic causation is not implicated. (OpenTargets Search: Otofacial neurodevelopmental syndrome, owrang2025neurogeneticdisorderswith pages 13-14)

Suggested annotations include:

  • Gene/protein: ZSCAN10; ENSG00000130182.
  • Variant concepts: sequence variant; frameshift variant; stop-gained variant; loss-of-function variant; germline variant.
  • Inheritance: autosomal recessive.
  • Molecular-function GO labels: DNA-binding transcription-factor activity; sequence-specific DNA binding.
  • Cellular-component GO label: nucleus.
  • Biological-process GO labels: regulation of transcription by RNA polymerase II; stem-cell population maintenance; regulation of cell differentiation; embryonic development.

The retrieved evidence did not establish HGNC ID, UniProt accession, exact transcript, exact HGVS variants, gnomAD frequencies, ACMG criteria applied to each variant, penetrance, or pathogenicity of individual ClinVar records. Likewise, no modifier genes, syndrome-specific methylation signature, chromosomal rearrangement, copy-number mechanism, or repeat expansion is established.

5. Environmental information

Environmental, lifestyle, occupational, infectious, and toxicologic factors are not applicable as demonstrated primary causes. There is no evidence for infection-triggered disease or zoonotic transmission. General avoidance of ototoxic drugs is prudent for a person with SNHL, but it does not prevent the underlying genetic syndrome and is not a ZSCAN10-specific intervention.

6. Mechanism and pathophysiology

Current causal model

The best-supported chain is:

biallelic truncating ZSCAN10 variants → ZSCAN10 deficiency → disruption of transcriptional regulation during embryonic stem-cell pluripotency/lineage specification → abnormal neural and cranio-otic development → developmental delay, facial asymmetry, external-ear malformations, semicircular-canal dysplasia, and SNHL.

The first two links are genetically established; ZSCAN10’s role in embryonic stem-cell pluripotency is established gene biology; the tissue-specific developmental links are biologically plausible interpretations of the human phenotype but remain incompletely mapped. The review identifies ZSCAN10 as a transcription factor that “controls pluripotency of embryonic stem cells.” (owrang2025neurogeneticdisorderswith pages 13-14)

Upstream versus downstream

  • Upstream: germline loss-of-function alleles and deficient transcription-factor activity.
  • Intermediate: altered developmental transcriptional programs and cell-fate decisions; exact targets are unknown.
  • Downstream: malformation of craniofacial/external-ear structures and the semicircular canals, plus neurodevelopmental and auditory dysfunction.

No disease-specific evidence currently establishes Wnt, MAPK, mTOR, PI3K–AKT, immune activation, oxidative stress, apoptosis, autophagy, fibrosis, enzyme deficiency, receptor dysfunction, ion-channel dysfunction, or a metabolic lesion. No syndrome-specific transcriptomic, proteomic, metabolomic, lipidomic, methylomic, single-cell, spatial-transcriptomic, multi-omic, CRISPR-screen, or patient-iPSC dataset was identified.

Suggested cell types—only as developmental hypotheses—include neural progenitor cells, cranial neural-crest derivatives, otic progenitors, cochlear sensory hair cells, and vestibular sensory cells. Candidate Cell Ontology labels include neural progenitor cell, neural crest cell, hair cell, and sensory neuron. These should be tagged “inferred,” not “experimentally demonstrated.”

7. Anatomical structures affected

Established or strongly indicated anatomical domains are:

  • Nervous system/brain: inferred from global developmental delay; no specific cerebral lesion was recoverable.
  • Craniofacial complex: facial asymmetry.
  • External ear/pinna: congenital malformation.
  • Inner ear/vestibular labyrinth: semicircular-canal dysplasia.
  • Auditory system: SNHL, with the precise cochlear, neural, or mixed lesion not established.

Suggested UBERON labels are brain, face, external ear, inner ear, vestibular labyrinth, semicircular canal, cochlea, and auditory system. Suggested subcellular annotation is nucleus, reflecting transcription-factor localization. Laterality and degree of asymmetry were not available. (owrang2025neurogeneticdisorderswith pages 13-14)

8. Temporal development

The structural ear and facial findings imply prenatal/congenital origin; developmental delay and hearing impairment become clinically evident during infancy or childhood. The disease is expected to be lifelong. However, there is no longitudinal cohort establishing progression, developmental plateau, neurodegeneration, episodic worsening, remission, or adult natural history.

A critical practical period is early childhood, when hearing detection and language intervention may influence developmental trajectory. The expert review notes that hearing loss may occur early in neurogenetic disease and sometimes precede overt neurological findings. (owrang2025neurogeneticdisorderswith pages 13-14)

9. Inheritance and population

  • Inheritance: autosomal recessive, biallelic.
  • Penetrance: apparently high for the core phenotype among reported biallelic cases, but seven individuals are insufficient to estimate penetrance.
  • Expressivity: likely variable, particularly for hearing loss, because only 4/5 tested individuals had confirmed SNHL; incomplete testing prevents a firm estimate.
  • Anticipation: not expected and not reported.
  • Germline mosaicism: not reported; a low residual recurrence risk may remain after apparently de novo findings, although de novo biallelic causation was not established here.
  • Founder effects, consanguinity, carrier frequency, sex ratio, ancestry effects, and geographic clustering: unknown.
  • Prevalence/incidence: unknown. Only seven cases were documented in the foundational report, which supports classification as ultra-rare but cannot yield a population prevalence. (owrang2025neurogeneticdisorderswith pages 13-14, owrang2025neurogeneticdisorderswith pages 18-19)

For confirmed carrier parents, the standard Mendelian expectation is a 25% affected, 50% carrier, and 25% unaffected/non-carrier probability in each pregnancy, assuming both parents carry pathogenic variants in the same gene.

10. Diagnostics

Recommended clinical work-up

There are no formal syndrome-specific diagnostic criteria. A reasonable approach is:

  1. Document developmental history, neurologic findings, facial asymmetry, and external-ear morphology.
  2. Perform age-appropriate audiology—otoacoustic emissions, auditory brainstem response in infants or uncooperative children, and behavioral pure-tone/speech audiometry when feasible.
  3. Use high-resolution temporal-bone MRI or CT when inner-ear malformation is suspected; MRI documented semicircular-canal dysplasia in the reported syndrome.
  4. Obtain developmental, speech-language, vestibular, and otolaryngologic assessments.
  5. Confirm two pathogenic/likely pathogenic ZSCAN10 variants in trans, with parental segregation where possible. (owrang2025neurogeneticdisorderswith pages 13-14)

Genetic-testing strategy

  • Preferred discovery test: trio whole-exome sequencing or whole-genome sequencing for syndromic developmental delay with hearing/ear anomalies.
  • Panel testing: include ZSCAN10 on neurodevelopmental-disorder, syndromic hearing-loss, congenital ear-malformation, or intellectual-disability panels.
  • Single-gene testing: suitable when the phenotype is highly characteristic or familial variants are known.
  • Deletion/duplication analysis: consider if sequencing finds only one allele, although a ZSCAN10 copy-number mechanism was not established in the retrieved evidence.
  • CMA: useful for the broader differential diagnosis but does not reliably detect small sequence variants.
  • Karyotype/FISH, mitochondrial DNA, and repeat-expansion tests: not first-line tests for this specific molecular diagnosis.
  • RNA sequencing: potentially useful to resolve splice variants, but no disease-specific diagnostic validation exists.

The 2025 review’s expert recommendation is that hearing loss in a child with developmental delay, hypotonia, or unexplained regression should prompt a neurogenetic diagnosis. (owrang2025neurogeneticdisorderswith pages 13-14)

Differential diagnosis

Consider other syndromic causes combining neurodevelopmental impairment and hearing or ear malformations, including CHARGE syndrome/CHD7 disorder, branchio-oto-renal spectrum, Kabuki syndrome, craniofacial microsomia, and other recently defined neurogenetic hearing-loss disorders. Distinguishing features for ZSCAN10 deficiency are recessive inheritance and the combination of facial asymmetry, external-ear malformation, semicircular-canal dysplasia, and developmental delay. Because the cohort is very small, this gestalt is supportive rather than diagnostic.

11. Outcome and prognosis

Survival, mortality, life expectancy, adult independence, seizure risk, and long-term neurologic progression have not been quantified. No disease-specific prognostic biomarkers or prediction model exists. Likely morbidity arises from developmental disability and hearing impairment. Recovery of the congenital syndrome is not expected, although hearing, communication, education, and adaptive function may improve with early supportive intervention. No formal quality-of-life or disability-scale data are available.

12. Treatment

There is no approved disease-modifying therapy, genotype-specific drug, gene therapy, RNA therapy, cell therapy, immunotherapy, or registered disease-specific interventional trial in the retrieved evidence.

Management should therefore be individualized and multidisciplinary:

  • early-developmental services and special education;
  • speech-language therapy, including augmentative and alternative communication when required;
  • audiology and otolaryngology follow-up;
  • hearing aids where residual hearing permits;
  • cochlear-implant evaluation for severe/profound SNHL, with anatomy assessed because semicircular-canal dysplasia is present;
  • occupational and physical therapy according to functional deficits;
  • vestibular assessment and balance therapy if symptomatic;
  • clinical-genetics follow-up and family counseling.

These are extrapolated standards for developmental disability and pediatric SNHL, not interventions tested specifically in ZSCAN10 deficiency. Suitable NCIT concept labels include Genetic Counseling, Audiologic Examination, Hearing Aid, Cochlear Implantation, Speech and Language Therapy, Occupational Therapy, and Physical Therapy.

No response rates, adverse-event series, pharmacogenomic recommendations, combination algorithms, or experimental NCT identifiers exist for this syndrome.

13. Prevention

Primary prevention through lifestyle modification, vaccination, or avoidance of an exposure is not available. Reproductive prevention options after familial variants are known include carrier testing of relatives, prenatal diagnosis, and preimplantation genetic testing for monogenic disease. Secondary prevention consists of early molecular diagnosis, audiologic surveillance, and prompt developmental/hearing intervention. Tertiary prevention aims to limit communication, educational, balance, and functional complications. Genetic counseling should explain autosomal-recessive recurrence and available reproductive choices.

Population newborn genomic or carrier screening is not currently supported by prevalence, natural-history, or implementation evidence. Standard newborn hearing screening may detect hearing impairment but is neither sensitive nor specific for ZSCAN10 deficiency.

14. Other species and natural disease

No naturally occurring ZSCAN10-related otofacial neurodevelopmental syndrome was identified in companion animals, livestock, or wildlife. No breed association, OMIA entry, veterinary burden, cross-species transmission, or zoonotic potential was established. Orthologues likely exist in standard vertebrate models, but NCBI Gene and taxon identifiers should be verified directly before database import.

15. Model organisms and experimental systems

The retrieved literature supports a role for ZSCAN10 in embryonic stem-cell pluripotency and transcriptional regulation, but it did not establish a syndrome-specific knockout or knock-in animal model that recapitulates the human neurodevelopmental, external-ear, semicircular-canal, and hearing phenotypes. Accordingly, no model can yet be rated for phenotypic fidelity. (owrang2025neurogeneticdisorderswith pages 13-14)

High-priority future models are:

  • CRISPR ZSCAN10-null human iPSCs differentiated toward neural-crest, neural, and otic lineages;
  • patient-derived iPSCs with isogenic correction;
  • zebrafish or mouse knockout/knock-in models assessed for craniofacial symmetry, ear morphology, vestibular function, auditory thresholds, and neurobehavior;
  • rescue experiments restoring wild-type ZSCAN10 to establish causal reversibility;
  • single-cell RNA/ATAC sequencing during otic and neural differentiation to identify downstream transcriptional targets.

These are proposed research applications, not currently validated implementations.

Overall assessment

The syndrome–gene relationship is supported by a coherent 2024 human cohort, recessive loss-of-function genetics, and a biologically plausible role for ZSCAN10 in developmental transcription. Its defining clinical signal is the conjunction of developmental delay with characteristic otofacial and inner-ear abnormalities. Nevertheless, the evidence base remains at the initial disease-description stage: seven cases, incomplete hearing testing, no prevalence estimate, no longitudinal natural history, no disease-specific therapy, and no validated model or molecular biomarker. The immediate real-world application is therefore improved genomic diagnosis and early audiologic/developmental management—not molecularly targeted treatment. (owrang2025neurogeneticdisorderswith pages 13-14, OpenTargets Search: Otofacial neurodevelopmental syndrome)

References

  1. (OpenTargets Search: Otofacial neurodevelopmental syndrome): Open Targets Query (Otofacial neurodevelopmental syndrome, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  2. (owrang2025neurogeneticdisorderswith pages 13-14): Daniel Owrang and Barbara Vona. Neurogenetic disorders with hearing loss: mechanisms, classifications, and emerging insights. Current Neurology and Neuroscience Reports, Nov 2025. URL: https://doi.org/10.1007/s11910-025-01466-y, doi:10.1007/s11910-025-01466-y. This article has 2 citations and is from a domain leading peer-reviewed journal.

  3. (owrang2025neurogeneticdisorderswith pages 18-19): Daniel Owrang and Barbara Vona. Neurogenetic disorders with hearing loss: mechanisms, classifications, and emerging insights. Current Neurology and Neuroscience Reports, Nov 2025. URL: https://doi.org/10.1007/s11910-025-01466-y, doi:10.1007/s11910-025-01466-y. This article has 2 citations and is from a domain leading peer-reviewed journal.

Artifacts